Metrics
Publication
606
Open Access
50
UN Sustainable Development Goals
Education
2021 - 2022
2021 - 2022Post Doctorate
University of Oxford, Neurology, England
2006 - 2007
2006 - 2007Post Doctorate
University of Pennsylvania, Neurology, United States Of America
2001 - 2006
2001 - 2006Post Doctorate
University of Texas at Austin, University Of Texas Medical Branch, Galveston, Tx, Abd, United States Of America
2000 - 2001
2000 - 2001Post Doctorate
University of Oxford, Neurology, United Kingdom
1995 - 2000
1995 - 2000Expertise In Medicine
Istanbul University, Istanbul Medical Faculty, Nöroloji, Turkey
1991 - 1995
1991 - 1995Masters (Non-Thesis)
Istanbul University, Istanbul Medical Faculty, Turkey
1989 - 1991
1989 - 1991Undergraduate
Istanbul University, Istanbul Medical Faculty, Turkey
Dissertations
2000
2000Expertise In Medicine
Diabetes mellitus olgularında subklinik polinöropati araştırmasında F takeodispersiyonun yeri 
Istanbul University, Istanbul Medical Faculty, Nöroloji
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
Research Areas
Medicine
Health Sciences
Fundamental Medical Sciences
Internal Medicine Sciences
Neurology
Life Sciences
Neurobiology
Natural Sciences
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2015 - Present
2015 - PresentProfessor
Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience
2011 - 2015
2011 - 2015Associate Professor
Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience
Managerial Experience
2021 - Present
2021 - PresentNeuro-oncology Board
EAN - European Academy of Neurology, Scientific Boards
2019 - 2022
2019 - 2022Uluslararası İşbirliği Projeleri Araştırma Destek Grubu (UPAG)
The Scientific and Technological Research Council of Turkey
2012 - 2022
2012 - 2022Head of Department
Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience
Non Academic Experience
2021 - 2022
2021 - 2022Sabbatical
Oxford Üniversitesi, Sabbatical
2006 - 2007
2006 - 2007Doktora sonrası araştırmacı
UPenn, PA, ABD, Doktora sonrası araştırmacı
2001 - 2006
2001 - 2006Doktora sonrası araştırmacı
UTMB, TX, ABD, Doktora sonrası araştırmacı
2000 - 2001
2000 - 2001Doktora sonrası araştırmacı
Oxford Üniversitesi, Doktora sonrası araştırmacı
Supervised Theses
2024
2024Doctorate
Multipl sklerozda periferik regülatör hücre fonksiyonlarının hastalık patogenezi ile ilişkisinin değerlendirilmesi
Tüzün E. (Advisor)
E.AKBAYIR(Student)
2024
2024Postgraduate
Huzursuz bacak sendromu'nda periferik kan gen ekspresyon düzeylerinin araştırılması
Tüzün E. (Advisor)
A.GÜLÇİÇEK(Student)
2023
2023Doctorate
Dijital manipülasyonun yutmadaki etkinliği
Tüzün E. (Advisor)
G.KÖPRÜCÜ(Student)
2023
2023Doctorate
Multipl skleroz hastalığında miRNA'ların biyobelirteç olarak araştırılması
Tüzün E. (Advisor)
F.SAĞIR(Student)
2020
2020Postgraduate
KİS'TEN RRMS'YE DÖNÜŞEN OLGULARDA B HÜCRE SPESİFİK GEN EKSPRESYON DÜZEYLERİNİN BELİRLENMESİ
Tüzün E. (Advisor)
İ.ERDEM(Student)
2020
2020Doctorate
Nörodejeneratif hastalıklarda hücresel senesans mekanizmasının rolü
Tüzün E. (Advisor)
Y.MERİÇ(Student)
2019
2019Doctorate
İdiyopatik intrakraniyal hipertansiyon (İİH) hastalığında antinöronal membran antikorlarının araştırılması
Tüzün E. (Advisor)
B.YETİMLER(Student)
2019
2019Doctorate
Genetik absans epilepsi modeli WAG/Rij sıçanlarda nanopartikül bağlı antiepileptik ilacın kan-beyin bariyeri dinamikleri ve antiepileptojenik etkileri
Tüzün E. (Advisor)
A.TEMİZYÜREK(Student)
2019
2019Postgraduate
Benign MS hastalarının B hücre immünfenotiplenmesi ve B hücresine özgü moleküllerin ekspresyon analizi
Tüzün E. (Advisor)
M.ŞEN(Student)
2019
2019Postgraduate
MS hastalarının bellek protein ekspresyon düzeylerinin kognitif rehabilitasyona bağlı değişimlerinin incelenmesi
Tüzün E. (Advisor)
E.AKBAYIR(Student)
2019
2019Doctorate
Rolandik epilepsi olgularında dil bozuklukları ile anti nöronal antikor ilişkisinin incelenmesi
Tüzün E. (Advisor)
M.SAVAŞ(Student)
2019
2019Doctorate
Multiple skleroz patofizyolojisinde perisitlerin rolü
Tüzün E. (Advisor)
C.AYSEL(Student)
2019
2019Postgraduate
Glisin reseptör antikoru pozitif kriptojenik fokal epilepside periferik kan hücrelerinin immünfenotiplendirilmesi ve antijenik yanıtlarının araştırılması
Tüzün E. (Advisor)
E.ŞANLI(Student)
2018
2018Doctorate
Parkinson hastalığında görülen kognitif bozulmanın nörobiyolojik mekanizmalarının genetik ve nörogörüntüleme yaklaşımlarıyla incelenmesi
Tüzün E. (Advisor)
A.KIÇİK(Student)
2017
2017Doctorate
Nöro-Behçet Olgularının Serum İmmünoglobulin Örneklerinin Nöronal Sağkalım Üzerine Etkileri
TÜZÜN E.
E.Erdağ(Student)
2017
2017Postgraduate
Paraneoplastik nörolojik sendromlu kanser olgularında anti-nöronal antikorların prognostik değeri
Tüzün E. (Advisor)
Ç.AYDIN(Student)
2017
2017Doctorate
İyon kanalı antikorlarının nöronal membran protein ekspresyonu ve sağkalım üzerine etkileri
Tüzün E. (Advisor)
N.ALTUNCU(Student)
2016
2016Postgraduate
MUSK-REAKTİF LENFOSİTLERİN DENEYSEL OTOİMMÜN MİYASTENİA GRAVİS MODELİNDE KARAKTERİZASYONU VE BİYOBELİRTEÇ OLARAK DEĞERLERİNİN ARAŞTIRILMASI
TÜZÜN E.
M.Küçükerden(Student)
2016
2016Postgraduate
P2 pürinerjik reseptörlerinin nöronal sağkalım sürecindeki değişimleri
Tüzün E. (Advisor)
A.ÖRÇEN(Student)
2016
2016Postgraduate
Bipolar hastalarda nöroinflamasyon ve nöronal yıkım belirteçlerinin farklı hastalık alt gruplarında karşılaştırılmalı incelenmesi
Tüzün E. (Advisor)
U.AKCAN(Student)
2015
2015Postgraduate
Parkinson hastalığı ve akciğer kanserinde dj-1 ve αlfa-sinüklein'in ortak PI3K/AKT yolağı üzerindeki etkilerinin karşılaştırılması
Tüzün E. (Advisor)
N.YALÇINKAYA(Student)
2014
2014Postgraduate
Parkinson hastalığı'nın hayvan modelinde PI3K/Akt yolağı ile mitokondriyal, oksidatif ve apoptotik parametrelerin ilişkisi
Tüzün E. (Advisor)
H.HAYTURAL(Student)
2013
2013Postgraduate
Deneysel otoimmün MuSK miyastenia graviste sitokinlerin rolü
Tüzün E. (Advisor)
C.AYSEL(Student)
Articles
All (376)
SCI-E, SSCI, AHCI (308)
SCI-E, SSCI, AHCI, ESCI (320)
ESCI (11)
Scopus (325)
TRDizin (65)
Other Publications (41)
2025
20251. Cognitive Outcome in a Case of Herpes Simplex Virus Encephalitis-induced Anti-N-methyl-D-aspartate Receptor Encephalitis
Şişman Bayar A. B., Bayar M. D., Savaş M., Atacan Yaşgüçlükal M., Şen Ö., Tüzün E.
Neurological Sciences and Neurophysiology
, vol.42, no.4, pp.190-193, 2025 (Peer-Reviewed Journal)
2025
20252. MOG and GFAP Antibodies are not Present in Headache with Neurological Deficits and Cerebrospinal Fluid Lymphocytosis (HaNDL)
Pechlivanidou M., Şanlı E., Kürtüncü M., Tzartos J., Tzartos S., Tüzün E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.62, no.4, pp.293-294, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
20253. Peripheral cytokine levels in patients with idiopathic parkinson's disease undergoing subthalamic nucleus deep brain stimulation.
Kocabıcak E., Sen S., Uzun H., Ozturk S., Yildiz M. O., Tuzun E., et al.
Scientific reports
, vol.15, no.1, pp.36719, 2025 (SCI-Expanded)
2025
20254. A Comprehensive Overview of the Clinical, Electrophysiological, and Neuroimaging Features of BPAN: Insights From a New Case Series
Susgun S., Kizek O., Ugur Iseri S. A., Kamaci I., Elmali A. D., Iscen P., et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
, 2025 (SCI-Expanded, Scopus)
2025
20255. Short and Long-Term Effects of Intravenous Methylprednisolone and Plasma Exchange Combination in NMOSD Attacks.
Yaşargün D. Ö., Ersöz A. S., Türkoğlu R., Tüzün E.
Noro psikiyatri arsivi
, vol.62, no.4, pp.354-359, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
20256. Investigation of symptom-specific functional connectivity patterns in Parkinson's disease
Kicik A., Bayram A., Erdogdu E., Kurt E., Saridede D. B., Cengiz S., et al.
NEUROLOGICAL SCIENCES
, vol.46, no.9, pp.4385-4396, 2025 (SCI-Expanded, Scopus)
2025
20257. Hock immunization, a refined alternative for developing experimental autoimmune myasthenia gravis (EAMG) in mice.
Mané-Damas M., Schöttler A. K., Mohile T., Arets B., Tüzün E., Losen M., et al.
Scientific reports
, vol.15, no.1, pp.31893, 2025 (SCI-Expanded, Scopus)
2025
20258. Binding patterns of glycine receptor autoantibodies are related to clinical syndromes.
Piro I., Wiessler A., Kakavela E., Baykan B., Tüzün E., Villmann C., et al.
Acta neuropathologica communications
, vol.13, no.1, pp.166, 2025 (SCI-Expanded)
2025
20259. Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms.
van de Burgt N. A., Kulsvehagen L., Mané-Damas M., Lutz L., Lecourt A., Monserrat C., et al.
Frontiers in neurology
, vol.16, pp.1593042, 2025 (SCI-Expanded)
2025
202510. Baseline neurofilament light chain and brain-derived neurotrophic factor levels predict development of aggressive multiple sclerosis.
Erol Yildiz R., Akbayir E., Kizilay T., Ersöz A. S., Özkan Yaşargün D., Süer D., et al.
Turkish journal of medical sciences
, vol.55, no.5, pp.1122-1129, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
202511. Active Immunization for Inducing Autoimmune Muscle-Specific Kinase (MuSK) Myasthenia Gravis in Mice
Koral G., Yılmaz V., Ulusoy C. A., Lazaridis K., Tüzün E.
Journal of Visualized Experiments
, vol.2025, no.221, 2025 (SCI-Expanded, Scopus)
2025
202512. Clinical characteristics and prognostic clinical factors of anti-gamma-aminobutyric acid-B receptor (GABAB-R) encephalitis in Türkiye: a multicenter study.
Gozubatik-Celik R. G., Baykan B., Emekli A. S., Tuzun E., Soysal A., Uzunkopru C., et al.
Neurological research
, vol.47, no.7, pp.612-625, 2025 (SCI-Expanded, Scopus)
2025
202513. Early Electrodiagnostic Study in Guillain-Barré Syndrome Requires a Second One for Accurate Electrodiagnosis
Tasdemir V., Sirin N. G., Oge A. E., Cakar A., Culha A., Soysal A., et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY
, vol.42, no.5, pp.470-471, 2025 (SCI-Expanded, Scopus)
2025
202514. Investigating the Effects of NMDAR and LGI1 Antibodies on Absence Seizures: Insights from Genetic Absence Epilepsy Rats and Acute Pharmacological Model of Absence Seizures.
Çarçak N., Korkmaz H. Y., Pişkin Ş. A., Yalçın B., Çırak S., Ulusoy C., et al.
Noro psikiyatri arsivi
, vol.62, no.3, pp.279-285, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
202515. Pediatric case of Kelch-like protein 11 (KLHL11) encephalitis with long-term follow-up: pitfalls in diagnosis of pediatric autoimmune encephalitis.
Şanlı E., Pechlivanidou M., Akbeyaz H., Savaş M., Takış G., Tzartos J., et al.
Noro psikiyatri arsivi
, vol.62, no.2, pp.97-99, 2025 (SCI-Expanded)
2025
202516. Treatment-resistant patients with focal epilepsy of unknown cause display reduced neurogranin levels: a preliminary study.
Aysel Ş. B., Merve S., Gizem K., Muhammet B. D., Oğuz Y., Aytül M., et al.
Ideggyogyaszati szemle
, vol.78, no.5-6, pp.163-168, 2025 (SCI-Expanded)
2025
202517. Longitudinal Investigation of Brain and Spinal Cord Pericytes After Inducible PDGFRβ+ Cell Ablation in Adult Mice
Atak D., Yıldız E., Özkan E., Yousefi M., Özkan A., Yılmaz A. B., et al.
Journal of Neurochemistry
, vol.169, no.3, pp.70035, 2025 (Peer-Reviewed Journal)
2025
202518. Renal Expression Levels of C5a Receptor and Autophagy-related Beclin-1 and LC3A/B Are Simultaneously Enhanced Under Immunoglobulin Treatment in a Rat Model of Sepsis.
Polat Ö., Orhun G., Anakli I., Yilmaz V., Koral G., Ulusoy C., et al.
In vivo (Athens, Greece)
, vol.39, no.2, pp.810-818, 2025 (SCI-Expanded)
2025
202519. Reparixin as a Potential Antiepileptogenic Agent: Modulation of the CXCL1–CXCR1/2 Axis and Seizure Activity in a Kindling Rat Model of Temporal Lobe Epilepsy
Çarçak Yılmaz N., Mutlu N., Erdeve E. T., Turan T. T., Sarıyıldız Ö., Ulusoy C. A., et al.
International Journal of Molecular Sciences
, vol.26, no.7, pp.2831, 2025 (Scopus)
2025
202520. Impaired Presynaptic Function Contributes Significantly to the Pathology of Glycine Receptor Autoantibodies.
Wiessler A., Zheng F., Werner C., Habib M., Tuzun E., Alzheimer C., et al.
Neurology(R) neuroimmunology & neuroinflammation
, vol.12, no.2, 2025 (SCI-Expanded)
2025
202521. Effects of immune modulatory treatment on language and psychiatric profile in patients with electrical status epilepticus in sleep (ESES)
Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., İşcen P., Topaloğlu P., et al.
EPILEPSY & BEHAVIOR
, vol.163, 2025 (SCI-Expanded, Scopus)
2025
202522. B-Cell and T-Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis
Akbayır E., Kızılay T., Erol R., Özkan Yaşargün D., Tüzün E., Yılmaz V., et al.
In Vivo
, vol.39, no.2, pp.1162-1172, 2025 (Peer-Reviewed Journal)
2025
202523. N-Methyl-D-Aspartate Receptor (NMDAR) Antibodies Induce Diverse Calcium Activity Patterns on Cultured Astrocytes and Astrocyte–Neuron Cocultures
AYŞİT N., BOSTAN S., ULUSOY C. A., TÜZÜN E., BAYAT F. K.
Acta Neurologica Scandinavica
, vol.2025, no.1, 2025 (SCI-Expanded, Scopus)
2025
202524. Seronegative NMOSD patients display distinctive peripheral blood T-cell subset frequencies
Sanli E., Karaaslan Z., Yilmaz V., Gunduz T., Kurtuncu M., Turkoglu R., et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
, vol.219, 2025 (SCI-Expanded, Scopus)
2025
202525. Differentiating multiple sclerosis with predominant spinal cord and optic nerve involvement from other autoimmune demyelinating diseases using B cell immunophenotyping and gene expression profiling.
Yilmaz V., Karaaslan Z., Sanli E., Yuceer-Korkmaz H., Ulusoy C. A., Timirci-Kahraman Ö., et al.
Multiple sclerosis and related disorders
, vol.93, pp.106238, 2025 (SCI-Expanded)
2025
202526. Sodium/Potassium-transporting ATPase Subunit Alpha-3 Antibody is not Present in Patients with Idiopathic Intracranial Hypertension
KÜÇÜKALİ C. İ., Soylu S., Ulusoy C., TÜZÜN E.
Haseki Tip Bulteni
, vol.63, no.1, pp.6-11, 2025 (ESCI, Scopus, TRDizin)
2024
202427. Cognitive Dysfunction in Multiple Sclerosis Patients with Hippocampal Antibodies.
Arsoy E., Yüceer H., Yalçın B., Günbek S., Tezel M., Türkoğlu R., et al.
Noro psikiyatri arsivi
, vol.61, no.4, pp.293-295, 2024 (SCI-Expanded)
2024
202428. The Fibrotic Response in Pericyte Culture Upon Exposure to Multiple Sclerosis Sera.
Şekerdağ-Kılıç E., Özkan E., Ulusoy C., Uçar E. A., Shomalizadeh N., Sapancı S., et al.
Noro psikiyatri arsivi
, vol.62, no.1, pp.69-76, 2024 (SCI-Expanded)
2024
202429. Distinctive sleep complaints and polysomnographic findings in antibody subgroups of autoimmune limbic encephalitis
Küçükali C. İ., Yılmaz V., Karadeniz D., Akyıldız U. O., İlhan Algın D., Sarıtaş A. Ş., et al.
NEUROLOGICAL SCIENCES
, vol.45, no.11, pp.5429-5439, 2024 (SCI-Expanded)
2024
202430. Patients with restless legs syndrome exhibit reduced serum colony-stimulating factor-1, humanin-like 3 and 10 levels
Gülçiçek A., Şanlı E., Şenel G. B., Karadeniz D., Timirci-Kahraman Ö., Küçükali C. İ., et al.
ACTA NEUROLOGICA BELGICA
, vol.124, no.5, pp.1561-1568, 2024 (SCI-Expanded)
2024
202431. Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study
Kızılay T., Akbayir E., Erol R., Demir A. S., Özkan Yaşargün D., Yilmaz V., et al.
European Neurology
, vol.87, no.4, pp.203-210, 2024 (SCI-Expanded)
2024
202432. Gene Expression Levels Related to Histone Acetylation are Altered in Parkinson Disease Patients Parkinson Hastalarında Histon Asetilasyonu ile İlgili Gen İfade Düzeylerinin Değişimi
Tunoğlu S., Yalçin B., Yenilmez Tunoğlu E. N., KARAASLAN Z., BİLGİÇ B., Hanağasi H. A., et al.
Noropsikiyatri Arsivi
, vol.61, no.3, pp.271-274, 2024 (SCI-Expanded)
2024
202433. The Association Between Serum Levels of Glial Biomarkers, Clinical Severity and Electro-encephalography Features in Idiopathic West and Lennox-Gastaut Syndromes
Charkazzade M., Soylu S., Tüzün E., Yılmaz V., Sezgin M., Yapıcı Z., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.61, no.2, pp.128-134, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
202434. Glycine Receptor β-Targeting Autoantibodies Contribute to the Pathology of Autoimmune Diseases.
Wiessler A., Talucci I., Piro I., Seefried S., Hörlin V., Baykan B. B., et al.
Neurology(R) neuroimmunology & neuroinflammation
, vol.11, no.2, 2024 (SCI-Expanded)
2024
202435. Autoimmune Encephalitis with Antibodies Against A-Amino-3hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor and γ-Aminobutyric Acid-Beta Receptor: Case Report
Doğan F. U., Samanci B., YILMAZ V., Hanağasi H. A., Gürvit İ. H., TÜZÜN E., et al.
Noropsikiyatri Arsivi
, vol.61, no.1, pp.94-96, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
202436. Electrodiagnostic methods to verify Guillain-Barré syndrome subtypes in Istanbul: A prospective multicenter study
Tasdemir V., Sirin N. G., Cakar A., Culha A., Soysal A., Elmali A. D., et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
, vol.29, no.1, pp.72-81, 2024 (SCI-Expanded, Scopus)
2024
202437. Peripheral blood regulatory B and T cells are decreased in patients with focal epilepsy
ŞANLI E., ŞİRİN İNAN N. G., KÜÇÜKALİ C. İ., Baykan B., ULUSOY C. A., BEBEK N., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.387, 2024 (SCI-Expanded, Scopus)
2024
202438. Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders
Pechlivanidou M., Vakrakou A. G., Karagiorgou K., Tüzün E., Karachaliou E., Chroni E., et al.
FRONTIERS IN IMMUNOLOGY
, vol.15, 2024 (SCI-Expanded)
2024
202439. Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause.
Tzartos J., Pechlivanidou M., Bosveli D., Ninou E., Yuceer H., Yalcin B., et al.
In vivo (Athens, Greece)
, vol.38, no.1, pp.351-357, 2024 (SCI-Expanded)
2024
202440. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes
Ozdag Acarli A. N., Tuzun E., Sanli E., Koral G., Akbayir E., Cakar A., et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
, vol.215, no.1, pp.65-78, 2024 (SCI-Expanded, Scopus)
2023
202341. [Cerebellar antibodies in post-stroke sera of acute ischemic stroke patients].
Atmaca M. M., Erdağ E., Demir S., Yüceer H., Atmaca M. Ç., Küçükali C. İ., et al.
Ideggyogyaszati szemle
, vol.76, no.11-12, pp.394-398, 2023 (SCI-Expanded)
2023
202342. Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice
Koral G., Ulusoy C., Cossins J., Lazaridis K., Türkoğlu R., Dong Y. Y., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.383, 2023 (SCI-Expanded, Scopus)
2023
202343. Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement
KARAASLAN Z., Şengül-Yediel B., Yüceer-Korkmaz H., ŞANLI E., GEZEN AK D., DURSUN E., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.78, 2023 (SCI-Expanded)
2023
202344. Distribution of peripheral blood mononuclear cell subtypes in patients with West syndrome: Impact of synacthen treatment
Soylu S., Cherkezzade M., Akbayır E., Korkmaz H., Koral G., Şanlı E., et al.
IMMUNOLOGY LETTERS
, vol.261, pp.17-24, 2023 (SCI-Expanded)
2023
202345. Demyelinating Inflammatory Disorders of the Central Nervous System in the Era of COVID-19: Cases with Mild Infectious Symptoms.
Yaşargün D. Ö., Türkoğlu R., Tüzün E.
Noro psikiyatri arsivi
, vol.60, no.3, pp.191-193, 2023 (SCI-Expanded)
2023
202346. Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
Pechlivanidou M., Xenou K., Tzanetakos D., Koutsos E., Stergiou C., Andreadou E., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
, vol.24, no.16, 2023 (SCI-Expanded)
2023
202347. Generalized Peripheric Nerve Hyperexcitability with Neuropathy: Case Series with Long-Term Outcome.
Akan O., Baysal L., Uzunhan T. A., Tüzün E.
Noro psikiyatri arsivi
, vol.61, no.2, pp.184-188, 2023 (SCI-Expanded)
2023
202348. Autoimmune Mechanisms in Focal Epilepsy of Unknown Cause
ŞANLI E., YILMAZ V., TÜZÜN E.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, vol.40, no.3, pp.113-121, 2023 (SCI-Expanded)
2023
202349. Serum IgG of patients with relapsing inflammatory optic neuropathy immunoreacts with Sox2-positive glial cells of the optic nerve
Erdağ E., Emekli A. S., Gündüz T., Küçükali C. İ., Kürtüncü M., Tüzün E.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.73, 2023 (SCI-Expanded)
2023
202350. Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis
Ho S., Oswald E., Wong H. K., Vural A., Yilmaz V., Tüzün E., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
, vol.10, no.2, 2023 (SCI-Expanded)
2023
202351. Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus.
Kilic H., Sahin S., Toprak M. F., Hatay G. H., Yilmaz K., Adrovic A., et al.
Clinical and experimental rheumatology
, vol.41, no.3, pp.753-757, 2023 (SCI-Expanded)
2023
202352. The Effect of Lidocaine on the Experimental Model of Streptozotocin-Induced Alzheimer's Disease.
Tamam Y., Yokuş B., Tamam C., Yüceer H., Karahan S., Em B., et al.
Noro psikiyatri arsivi
, vol.60, no.1, pp.68-72, 2023 (SCI-Expanded)
2023
202353. Glycine receptor autoantibody binding to the extracellular domain is independent from receptor glycosylation.
Rauschenberger V., Piro I., Kasaragod V. B., Hörlin V., Eckes A., Kluck C. J., et al.
Frontiers in molecular neuroscience
, vol.16, pp.1089101, 2023 (SCI-Expanded)
2023
202354. Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder
KARAASLAN Z., YILMAZ V., YÜCEER H., ŞANLI E., Akcay H. I., Kurtuncu M., et al.
Northern Clinics of Istanbul
, vol.10, no.3, pp.341-344, 2023 (ESCI)
2023
202355. Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy
ORHUN G., ESEN F., YILMAZ V., Ulusoy C., ŞANLI E., Yildirim E., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.133, no.3, pp.327-333, 2023 (SCI-Expanded, Scopus)
2023
202356. Immunoreactivity against SLC3A2 in high grade gliomas displays positive correlation with glioblastoma patient survival: Potential target for glioma diagnosis and therapy
Karakaş N., Topçu O., Tüzün E., Timirci Kahraman Ö., Sabancı P. A., Aras Y., et al.
Biorxiv
, vol.26, pp.525653, 2023 (Non Peer-Reviewed Journal)
2023
202357. Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis
Pişkin Ş. A., Korkmaz H., Ulusoy C. A., Şanlı E., Küçükali C. İ., Onat F., et al.
FRONTIERS IN IMMUNOLOGY
, vol.14, 2023 (SCI-Expanded, Scopus)
2023
202358. Cerebrospinal fluid and serum autoantibodies in drug-resistant temporal lobe epilepsies: case series
Canbaz Kabay S., Tüzün E., Akdağ G., Çetiner M., Ayas S., Özişik Karaman H., et al.
Osmangazi Tıp Dergisi , vol.45, no.1, pp.125-129, 2023 (Peer-Reviewed Journal)
2023
202359. Increased neuropil antibody prevalence in COVID-19 patients with acute ischemic stroke
Baştan B., ERDAĞ TURGEON E., ŞANLI E., Bayar M. D., Şişman A. B., Atacan Yaşgüçlükal M., et al.
Neurological Research
, vol.45, no.11, pp.988-993, 2023 (SCI-Expanded)
2023
202360. Effect of telerehabilitation on verbal and visual memory in multiple sclerosis patients: A 12-month follow-up study
Arsoy E., Pamuk S., Tüzün E., Türkoğlu R.
Journal of Multiple Sclerosis Research , vol.3, no.2, pp.30-36, 2023 (Peer-Reviewed Journal)
2023
202361. Perivascular PDGFRB+ cells accompany lesion formation and clinical evolution differentially in two different EAE models.
Şekerdağ-Kılıç E., Ulusoy C., Atak D., Özkan E., Gökyüzü A. B., Seyaj S., et al.
Multiple sclerosis and related disorders
, vol.69, no.1, pp.104428, 2023 (SCI-Expanded)
2022
202262. Neuropsychiatry in the Century of Neuroscience
Marangozoğlu Samanci B., Yildizhan E., Tüzün E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.59, pp.1-2, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202263. Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios
Oezguen N., Yılmaz V., Horvath T. D., Akbayir E., Haidacher S. J., Hoch K. M., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.68, 2022 (SCI-Expanded)
2022
202264. Permanent Impairment of Language Functions in an Adolescent Case of Autoimmune Encephalitis Adölesan Bir Otoimmün Ensefalit Vakasında Kalıcı Dil Fonksiyon Bozukluğu
ŞANLI E., Savaş M., Öztürk G., Findik O. T. P., Başoğlu S., Akbeyaz H., et al.
Noropsikiyatri Arsivi
, vol.59, no.4, pp.338-341, 2022 (SCI-Expanded)
2022
202265. The modulatory action of C-Vx substance on the immune system in COVID-19
Tahrali I., Akdeniz N., Yilmaz V., Kucuksezer U. C., Oktelik F. B., Ozdemir O., et al.
EMERGING MICROBES & INFECTIONS
, vol.11, no.1, pp.2698-2710, 2022 (SCI-Expanded, Scopus)
2022
202266. Cutaneous allodynia and thermal thresholds in chronic migraine: The effect of onabotulinumtoxinA.
Ozarslan M., Matur Z., Tuzun E., Oge A. E.
Clinical neurology and neurosurgery
, vol.220, pp.107357, 2022 (SCI-Expanded)
2022
202267. Reduced expression of inflammasome complex components in cluster headache.
Şahin E., Karaaslan Z., Şanlı E., Timirci Kahraman Ö., Ulusoy C., Kocasoy Orhan E., et al.
Headache
, vol.62, no.8, pp.967-976, 2022 (SCI-Expanded, Scopus)
2022
202268. Classical complement pathway factor alterations in narcolepsy.
Yüceer H., Gezen Ak D., Benbir Şenel G., Dursun E., Yilmaz V., Karadeniz D., et al.
Acta neuropsychiatrica
, vol.34, no.4, pp.212-219, 2022 (SCI-Expanded)
2022
202269. Do the neurologists recognize autoimmune epilepsy well enough? What is the effect of the pandemic on this matter?
Yavuz E. N. V., Altindag E., Tuzun E., Baykan B.
NEUROLOGICAL SCIENCES
, vol.43, no.8, pp.5029-5037, 2022 (SCI-Expanded)
2022
202270. Blood-brain barrier targeted delivery of lacosamide-conjugated gold nanoparticles: Improving outcomes in absence seizures.
Temizyürek A., Yılmaz C. U., Emik S., Akcan U., Atış M., Orhan N., et al.
Epilepsy research
, vol.184, pp.106939, 2022 (SCI-Expanded)
2022
202271. Immune modulation as a consequence of SARS-CoV-2 infection
Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz V., Küçüksezer U. C., Akdeniz N., et al.
FRONTIERS IN IMMUNOLOGY
, vol.13, 2022 (SCI-Expanded, Scopus)
2022
202272. Kv5.1 antibody in epilepsy patients with unknown etiology
KÜÇÜKALİ C. İ., Sengul B., Gezen-Ak D., Dursun E., ERDAĞ E., AKPINAR G., et al.
EPILEPSY RESEARCH
, vol.182, 2022 (SCI-Expanded)
2022
202273. Posterior Reversible Encephalopathy in Sepsis-Associated Encephalopathy: Experience from a Single Center.
Orhun G., Sencer S., Tüzün E., Bebek N., Ergin Özcan P., Barburoğlu M., et al.
Neurocritical care
, vol.36, pp.372-386, 2022 (SCI-Expanded, Scopus)
2022
202274. IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.
Koneczny I., Tzartos J., Mané-Damas M., Yilmaz V., Huijbers M. G., Lazaridis K., et al.
Frontiers in immunology
, vol.13, no.13, pp.834342, 2022 (SCI-Expanded)
2022
202275. CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
KARAASLAN Z., KÜRTÜNCÜ M., Akcay H. I., GÜNDÜZ T., Altunrende B., Turkoglu R., et al.
EUROPEAN NEUROLOGY
, vol.85, no.1, pp.69-71, 2022 (SCI-Expanded, Scopus)
2022
202276. Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.
Türkoğlu R., Baliç N., Kızılay T., Erol R., Akbayır E., Yılmaz V., et al.
Multiple sclerosis and related disorders
, vol.58, pp.103524, 2022 (SCI-Expanded)
2022
202277. The effects of demographic, clinical, and radiological parameters of multiple sclerosis on quality of life and fatigue
Arsoy E., Delipoyraz I., Bulut N., Tüzün E., Türkoğlu R.
Haydarpaşa Numune Hastanesi Tıp Dergisi , vol.62, no.2, pp.206-212, 2022 (Peer-Reviewed Journal)
2022
202278. Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behcet's disease
Karaaslan Z., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Akbayır E., Koral G., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.52, no.4, pp.1266-1273, 2022 (SCI-Expanded)
2022
202279. INCREASED SERUM CITRULLINATED HISTONE H3 LEVELS IN COVID-19 PATIENTS WITH ACUTE ISCHEMIC STROKE AKUT ISCHAEMIÁS STROKE-BAN SZENVEDÔ COVID-19-BETEGEK KÖRÉBEN MEGNÔ A SZÉRUM CITRULLINÁLT HISZTON H3-SZINTJE
Bayar M. D., Şişman A. B., Koral G., Çirak S., TÜZÜN E., Günaydin S., et al.
Ideggyogyaszati Szemle
, vol.75, no.5-6, pp.191-198, 2022 (SCI-Expanded)
2022
202280. Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination
Oktelik F. B., Yilmaz V., Gelmez M. Y., Akdeniz N., Pamukcu C., Sutlu T., et al.
CANADIAN JOURNAL OF MICROBIOLOGY
, vol.68, pp.543-550, 2022 (SCI-Expanded, Scopus)
2022
202281. Biomarker Value of Neurofilaments and Glial Fibrillary Acidic Protein in Central Nervous System Lymphoma and Tumors Merkezi Sinir Sistemi Lenfoma ve Tümörlerinde Nörofilamentlerin ve Glial Fibriler Asidik Proteinin Biyobelirteç Değeri
YÜCEER H., TÜZÜN E.
Noropsikiyatri Arsivi
, vol.59, no.4, pp.253-254, 2022 (SCI-Expanded)
2021
202182. Expression of Akt1 and p-Akt1 in peripheral T cell subsets of multiple sclerosis patients.
Oktelik F. B., Yilmaz V., Turkoglu R., Akbayir E., Tuzun E., Deniz G., et al.
Acta neurologica Belgica
, vol.121, no.6, pp.1777-1782, 2021 (SCI-Expanded, Scopus)
2021
202183. Phosphorylated Neurofilament Heavy Chain (pNFH) in Clinically Isolated Syndrome and Multiple Sclerosis
TÜZÜN E., ŞANLI E., Akbayir E., Turkoglu R.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.58, no.4, pp.255-256, 2021 (SCI-Expanded)
2021
202184. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study
SAĞIR F., Tunali N. E., TOMBUL T., Koral G., Cirak S., YILMAZ V., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, no.11, pp.720-726, 2021 (SCI-Expanded)
2021
202185. Cerebrospinal fluid level of phosphorylated neurofilament heavy chain is higher in converting clinically isolated syndrome and correlates with CAMP response element-binding protein concentration
Gencer M., Koral G., ŞANLI E., Cirak S., Akbayir E., YÜCEER H., et al.
Neurological Sciences and Neurophysiology
, vol.38, no.4, pp.256-261, 2021 (SCI-Expanded)
2021
202186. Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause.
Savaş M., Tzartos J., Küçükali C., Dursun E., Karagiorgou K., Gezen-Ak D., et al.
Acta neurologica Belgica
, vol.121, no.5, pp.1275-1280, 2021 (SCI-Expanded)
2021
202187. Leucine-Rich Glioma-Inactivated Protein 1 Antibody-Positive Polyradiculopathy Associated with Epstein-Barr Virus Infection.
Uzunalimoğlu B. P., Sağlam A., Şişman B., Günaydın S., Uzuner E. G., Aysal F., et al.
Case reports in neurology
, vol.13, no.2, pp.549-554, 2021 (ESCI)
2021
202188. Paraneoplastic cerebellar degeneration in a patient with multiple myeloma
KÜRTÜNCÜ M., TÜZÜN E.
LEUKEMIA & LYMPHOMA
, vol.62, no.10, pp.2556-2557, 2021 (SCI-Expanded)
2021
202189. Serum glial fibrillary acidic protein (GFAP)-antibody in idiopathic intracranial hypertension.
Yetimler B., Tzartos J., Şengül B., Dursun E., Ulukan Ç., Karagiorgou K., et al.
The International journal of neuroscience
, vol.131, no.8, pp.775-779, 2021 (SCI-Expanded)
2021
202190. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis
YILMAZ V., Ulusoy C., Hajtovic S., Turkoglu R., Kurtuncu M., Tzartos J., et al.
Immunological Investigations
, vol.50, pp.671-684, 2021 (SCI-Expanded, Scopus)
2021
202191. Peripheral blood B cell subset ratios and expression levels of B cell-associated genes are altered in benign multiple sclerosis
Turkoglu R., YILMAZ V., ÖZDEMİR Ö., Akbayir E., Benbir G., Arsoy E., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.52, 2021 (SCI-Expanded, Scopus)
2021
202192. Impact of Autoimmune Demyelinating Brain Disease Sera on Pericyte Survival
Ulusoy C., Şekerdağ E., YILMAZ V., Yilmaz A. B., Atak D., Vural A., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, no.2, pp.83-86, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202193. Aquaporin-4 Gene Polymorphisms in Relapsing Inflammatory Optic Neuropathy and RANKL in Glioblastoma: Research and Progress on Biomarkers.
Şanli E., Tüzün E.
Noro psikiyatri arsivi
, vol.58, no.2, pp.81-82, 2021 (SCI-Expanded)
2021
202194. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings
Noyan H., ERDAĞ E., TÜZÜN E., YAYLIM İ., KÜÇÜKHÜSEYİN Ö., HAKAN M. T., et al.
Schizophrenia Research
, vol.229, pp.27-37, 2021 (SCI-Expanded)
2021
202195. Tumefactive demyelinating lesions: A case series of 11 patients and review of the literature
Efendioğlu M., Kızılay T., Erol Yıldız R., Süer D., Karaaslan Z., Mısırlı C., et al.
Haydarpaşa Numune Hastanesi Tıp Dergisi , vol.61, no.3, pp.245-255, 2021 (Peer-Reviewed Journal)
2021
202196. The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigens.
Hoffmann C., Zong S., Mané-Damas M., Stevens J., Malyavantham K., Küçükali C. İ., et al.
Schizophrenia research
, vol.228, pp.462-471, 2021 (SCI-Expanded)
2021
202197. CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.
Tamam Y., Gunes B., Akbayir E., Kizilay T., Karaaslan Z., Koral G., et al.
Multiple sclerosis and related disorders
, vol.48, no.1, pp.102697, 2021 (SCI-Expanded)
2021
202198. Adaptive immunity cells are differentially distributed in the peripheral blood of glycine receptor antibody-positive patients with focal epilepsy of unknown cause.
Sanli E., Akbayir E., Kuçukali C. İ., Baykan B., Sirin N. G., Bebek N., et al.
Epilepsy research
, vol.170, pp.106542, 2021 (SCI-Expanded)
2021
202199. Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients.
Karaaslan Z., Kahraman Ö. T., Şanlı E., Ergen H. A., Ulusoy C., Bilgiç B., et al.
Scientific reports
, vol.11, no.1, pp.2316, 2021 (SCI-Expanded, Scopus)
2021
2021100. Central Role of T Follicular Helper Cells in Myasthenia Gravis.
Wu N., Tüzün E., Cheng Y., Yan L., Wu Y., Rao J., et al.
Noro psikiyatri arsivi
, vol.58, no.1, pp.68-72, 2021 (SCI-Expanded)
2021
2021101. Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?
Koneczny I., YILMAZ V., Lazaridis K., Tzartos J., Lenz T. L., Tzartos S., et al.
FRONTIERS IN IMMUNOLOGY
, vol.11, 2021 (SCI-Expanded)
2021
2021102. The effect of cognitive rehabilitation on peripheral blood B cell distribution and specific gene expression levels in MS patients
Akbayır E., Şen M., Arsoy E., Türkoğlu R., Yılmaz V., Tüzün E.
Journal of Multiple Sclerosis Research , vol.1, no.2, pp.32-39, 2021 (Peer-Reviewed Journal)
2021
2021103. Impact of calcitriol and an AKT inhibitor, AT7867, on survival of rat C6 glioma cells
KÜÇÜKHÜSEYİN Ö., ÇAKİRİS A., HAKAN M. T., Horozoglu C., TÜZÜN E., YAYLIM İ.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
, vol.35, no.1, pp.730-738, 2021 (SCI-Expanded)
2021
2021104. Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis
Culha Oktar A., Selcuk O., Elmas Tunc C., IŞILDAK Ş., ŞANLI E., YILMAZ V., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.51, no.5, pp.2570-2574, 2021 (SCI-Expanded)
2021
2021105. Expression levels of B cell receptor (BCR) signaling pathway factors are associated with conversion from clinically isolated syndrome to multiple sclerosis
Karaaslan Z., Akbayır E., Şanlı E., Şen M., Yüceer H., Türkoğlu R., et al.
EXPERIMED , vol.11, no.1, pp.33-37, 2021 (Peer-Reviewed Journal)
2020
2020106. The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients
YILMAZ V., TÜZÜN E., DURMUŞ TEKÇE H., Oflazer P., Aysal F., Parman Y., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.349, 2020 (SCI-Expanded, Scopus)
2020
2020107. Peripheral blood expression levels of inflammasome complex components in two different focal epilepsy syndromes
Ulusoy C., Vanlı-Yavuz E., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Bebek N., et al.
Journal of Neuroimmunology
, vol.347, 2020 (SCI-Expanded, Scopus)
2020
2020108. A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain
Sisman A. B., Bayar M. D., İçöz S., YILMAZ V., Kürtüncü M., TÜZÜN E., et al.
Case Reports in Neurology
, vol.12, no.3, pp.334-338, 2020 (ESCI)
2020
2020109. Determination of Paraneoplastic neuropathy in newly diagnosed breast tumor patients
Sayman C., Tireli H., Tüzün E., Günay Gürleyik M., Vardar Aker F.
eNeurologicalSci , vol.21, pp.100265, 2020 (Scopus)
2020
2020110. The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.
Arslan D. B., Gurvit H., Genc O., Kicik A., Eryurek K., Cengiz S., et al.
Journal of neural transmission (Vienna, Austria : 1996)
, vol.127, pp.1285-1294, 2020 (SCI-Expanded, Scopus)
2020
2020111. Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease
Gündüz T., Kürtüncü M., Matur Z., Tüzün E., Limon U., Tanyildiz B., et al.
Journal of the Neurological Sciences
, vol.414, 2020 (SCI-Expanded, Scopus)
2020
2020112. Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature.
Gulec B., Kurucu H., Bozbay S., Dikmen Y., Sayman H., Tuzun E., et al.
Multiple sclerosis and related disorders
, vol.42, pp.102075, 2020 (SCI-Expanded)
2020
2020113. Aquaporin-4 Gene Polymorphisms in Neuromyelitis Optica and Recurrent Optic Neuritis
Çakar A., Ulusoy C. A., İplik E. S., Küçükali C. İ., Tüzün E., Kürtüncü M.
Turkish Journal of Neurology , vol.26, no.2, pp.127-130, 2020 (Peer-Reviewed Journal)
2020
2020114. Nivolumab-induced autoantibody negative limbic encephalitis in a patient with Hodgkin lymphoma
Erol-Yıldız R., Kızılay T., TÜZÜN E., Mısırlı H., Türkoğlu R.
Leukemia and Lymphoma
, vol.61, no.6, pp.1519-1521, 2020 (SCI-Expanded)
2020
2020115. [Episodes with goose bumps caused by anti-LGI-1 encephalitis].
Johansson L., Esbjörnsson M., Tüzün E., van W., Baureder R., Sahin G.
Lakartidningen
, vol.117, no.117, 2020 (Scopus)
2020
2020116. Small ubiquitin-related modifier (SUMO) 3 and SUMO4 gene polymorphisms in Parkinson's disease
Küçükali C. İ., Salman B., Yüceer H., Ulusoy C. A., Abacı N., Ekmekci S., et al.
NEUROLOGICAL RESEARCH
, vol.42, no.6, pp.451-457, 2020 (SCI-Expanded, Scopus)
2020
2020117. Plasma levels of inflammatory mediators in vestibular migraine.
Karaaslan Z., Ozcelik P., Ulukan Ç., Ulusoy C. A., Orhan K. S., Orhan E., et al.
The International journal of neuroscience
, vol.130, no.4, pp.330-335, 2020 (SCI-Expanded, Scopus)
2020
2020118. NLRP1-Mediated Antidepressant Effect of Ketamine in Chronic Unpredictable Mild Stress Model in Rats.
Aricioğlu F., Yalcinkaya C., Ozkartal C., Tuzun E., Sirvanci S., Kucukali C. İ., et al.
Psychiatry investigation
, vol.17, pp.283-291, 2020 (SCI-Expanded)
2020
2020119. Serum immunoglobulin G of neuro-Behçet's Disease patients reduce cerebral expression levels of survival pathway factors
Erdağ E., Şahin Özkartal C., Küçükali C. İ., Arıcıoğlu F., Tüzün E.
Neurological Sciences and Neurophysiology , vol.37, no.3, pp.118-123, 2020 (Peer-Reviewed Journal)
2020
2020120. Absence of Autoantibodies Against Neuronal Surface Antigens in Sera of Patients With Psychotic Disorders
Hoffmann C., Zong S., Mané-Damas M., Molenaar P. C., Losen M., Titulaer M. J., et al.
JAMA Psychiatry , vol.77, no.3, pp.322-325, 2020 (Peer-Reviewed Journal)
2020
2020121. Diagnosing acute brain dysfunction due to sepsis
Esen F., Orhun G., Özcan P. E., Brenes Bastos A. R., TÜZÜN E.
Neurological Sciences
, vol.41, no.1, pp.25-33, 2020 (SCI-Expanded, Scopus)
2020
2020122. Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study
Tamam Y., Yuceer H., Duzel B., Sen M., Ulusoy C., Tuzun E.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY
, vol.45, no.2, pp.237-240, 2020 (SCI-Expanded, Scopus)
2020
2020123. Neuroimmunology of COVID-19
Ekizoğlu Turgut E., Tüzün E.
Türkiye Klinikleri Journal of Medical Research , vol.1, no.1, pp.1-5, 2020 (Peer-Reviewed Journal)
2020
2020124. Impact of epilepsy on language and discourse: Two self-limited focal epileptic syndromes of childhood
Savas M., TUNÇER A. M., Cokar A. O., Demirbilek A. V., Tuzun E.
EPILEPSY & BEHAVIOR
, vol.102, 2020 (SCI-Expanded)
2020
2020125. Investigation of IL-10 gene expression and rs1554286 SNP in Behçet's disease
Şehitoğlu Taşar E., Uğurel E., Tüzün E., Vural B.
EXPERIMED , vol.10, no.1, pp.25-29, 2020 (Peer-Reviewed Journal)
2020
2020126. Sleep disturbance and cognitive decline in multiple sclerosis patients with isolated optic neuritis as the first demyelinating event
Türkoğlu R., Benbir G., Özyurt S., Arsoy E., Akbayır E., Turan S., et al.
International Ophthalmology
, vol.40, no.1, pp.151-158, 2020 (SCI-Expanded)
2020
2020127. Neurocognitive decline caused by L-methionine: A mouse model of neurodegeneration
Altun Y., Tüzün E., Mehler M., Gökhan Ş.
EXPERIMED , vol.10, no.2, pp.59-66, 2020 (Peer-Reviewed Journal)
2019
2019128. Impact of fingolimod on CD4+T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients
Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Cinar S., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.337, 2019 (SCI-Expanded, Scopus)
2019
2019129. Antidepressant-like effects of agmatine and NOS inhibitors in chronic unpredictable mild stress model of depression in rats: The involvement of NLRP inflammasomes
Ozkartal C. S., Tuzun E., Kucukali C. I., Ulusoy C. A., Giris M., ARICIOĞLU F.
BRAIN RESEARCH
, vol.1725, 2019 (SCI-Expanded, Scopus)
2019
2019130. Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement
Sen M., Akbayir E., Mercan O., Arsoy E., Gencer M., Yilmaz V., et al.
JOURNAL OF SPINAL CORD MEDICINE
, 2019 (SCI-Expanded)
2019
2019131. Inflammatory biomarkers in epilepsy
Karaaslan Z., Tuzun E.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, vol.36, no.3, pp.129-135, 2019 (SCI-Expanded)
2019
2019132. Expression Levels of Inflammasome Complexes in Experimental Autoimmune Myasthenia Gravis Mouse Model (EAMG).
Baltacı C. N., YILMAZ V., ULUSOY C. A., TÜZÜN E., VURAL B.
Experimed , vol.9, no.3, pp.79-85, 2019 (Peer-Reviewed Journal)
2019
2019133. Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behcet's Disease
UGUREL E., ERDAG E., KUCUKALI C. İ., OLCAY A., Sanli E., AKBAYIR E., et al.
IN VIVO
, vol.33, no.5, pp.1493-1497, 2019 (SCI-Expanded)
2019
2019134. Neuroinflammation Mediators are Reduced in Sera of Parkinson's Disease Patients with Mild Cognitive Impairment.
Kıçık A., Tüzün E., Erdoğdu E., Bılgıç B., Tüfekçıoğlu Z., Öztürk-Işik E., et al.
Noro psikiyatri arsivi
, vol.57, pp.15-17, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
2019135. Inflammation and Neurodegeneration in Patients with Early-Stage and Chronic Bipolar Disorder
Karabulut S., Tasdemir I., Akcan U., Kucukali C. I., Tuzun E., Cakir S.
TURK PSIKIYATRI DERGISI
, vol.30, no.2, pp.75-81, 2019 (SSCI)
2019
2019136. Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis
Gencer M., Akbayir E., Sen M., Arsoy E., Yilmaz V., Bulut N., et al.
NEUROLOGICAL SCIENCES
, vol.40, no.5, pp.1067-1070, 2019 (SCI-Expanded)
2019
2019137. Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats
ARICIOĞLU F., Ozkartal C. S., Bastaskin T., Tuzun E., Kandemir C., ŞİRVANCI S., et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
, vol.17, no.2, pp.261-272, 2019 (SCI-Expanded)
2019
2019138. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid
Timirci-Kahraman O., Karaaslan Z., Tuzun E., Kurtuncu M., Baykal A. T., Gunduz T., et al.
ACTA NEUROLOGICA BELGICA
, no.1, pp.101-111, 2019 (SCI-Expanded)
2019
2019139. Association Between Inflammatory Markers and Cognitive Outcome in Patients with Acute Brain Dysfunction Due to Sepsis
Orhun G., Tuzun E., Ergin Ozcan P., Ulusoy C., Yildirim E., Kucukerden M., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.56, pp.63-70, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
2019140. Follow-up of patients with epilepsy harboring antiglycine receptor antibodies
EKIZOĞLU E., Baykan B., SEZGIN M., ERDAG E., GUNDOGDU-UNVERENGIL G., VANLı-YAVUZ E., et al.
EPILEPSY & BEHAVIOR
, pp.103-107, 2019 (SCI-Expanded)
2019
2019141. Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation
Duzel B., Tamam Y., Coban A., Tuzun E.
IMMUNOLOGICAL INVESTIGATIONS
, vol.48, no.2, pp.190-197, 2019 (SCI-Expanded)
2019
2019142. Neuroimaging Findings in Sepsis-Induced Brain Dysfunction: Association with Clinical and Laboratory Findings
Orhun G., Esen F., Ozcan P. E., Sencer S., Bilgic B., Ulusoy C., et al.
NEUROCRITICAL CARE
, vol.30, pp.106-117, 2019 (SCI-Expanded, Scopus)
2019
2019143. Insomnia and Dysautonomia with Contactin-Associated Protein 2 and Leucine-Rich Glioma Inactivated Protein 1 Antibodies: A "Forme Fruste" of Morvan Syndrome?
Bakircioglu-Duman E., Acar Z., Benbir G., Yuceer H., Acar H., Bastan B., et al.
CASE REPORTS IN NEUROLOGY
, vol.11, no.1, pp.80-86, 2019 (ESCI)
2019
2019144. Immunopathogenesis in neuromuscular junction disorders
Tüzün E.
Türkiye Klinikleri Journal of Medical Research , vol.12, no.1, pp.6-14, 2019 (Peer-Reviewed Journal)
2019
2019145. Brain Volume Changes in Patients with Acute Brain Dysfunction Due to Sepsis
Orhun G., TÜZÜN E., Bilgiç B., Ergin Özcan P., Sencer S., Barburoğlu M., et al.
Neurocritical Care
, 2019 (SCI-Expanded, Scopus)
2019
2019146. B cell immunophenotyping and expression analysis of B cell specific molecules of patients with benign multiple sclerosis
Şen M., Akbayır E., Türkoğlu R., Tüzün E., Yılmaz V.
EXPERIMED , vol.9, no.3, pp.105-112, 2019 (Peer-Reviewed Journal)
2019
2019147. Microbiota stratification identifies disease-specific alterations in neuro-Behcet's disease and multiple sclerosis
Oezguen N., Yalcinkaya N., Kucukali C. I., Dahdouli M., Hollister E. B., Luna R. A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, vol.37, no.6, pp.58-66, 2019 (SCI-Expanded)
2018
2018148. Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder
Hoffmann C., Stevens J., Zong S., van Kruining D., Saxena A., Kucukali C. I., et al.
PLOS ONE
, vol.13, no.12, 2018 (SCI-Expanded)
2018
2018149. Intracranial hypertension related to cerebral venous thrombosis; and acute ischemic stroke with micro-infarcts associated with IgG4-related disease
Ekizoglu E., Coban O., Ulukan C., Ak D. G., Dursun E., Tuzun E., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.128, no.11, pp.1097-1099, 2018 (SCI-Expanded)
2018
2018150. LRP4 antibody positive amyotrophic lateral sclerosis patients display neuropil-reactive IgG and enhanced serum complement levels
Tuzun E., Gezen-Ak D., Tzartos J., Dursun E., Giris M., Zisimopoulou P., et al.
IMMUNOLOGY LETTERS
, vol.203, pp.54-56, 2018 (SCI-Expanded)
2018
2018151. Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause
Tekturk P., Baykan B., Erdag E., Peach S., Sezgin M., Yapici Z., et al.
BRAIN & DEVELOPMENT
, vol.40, no.10, pp.909-917, 2018 (SCI-Expanded, Scopus)
2018
2018152. A SOD2 Polymorphism is Associated with Abnormal Quantitative Sensory Testing in Type 2 Diabetic Patients
Isikli A., Kubat-Uzum A., Satman I., Matur Z., Oge A. E., Kucukali M. I., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.55, no.3, pp.276-279, 2018 (SCI-Expanded)
2018
2018153. Evidence of linkage to chromosome 5p13.2-q11.1 in a large inbred family with genetic generalized epilepsy
Kinay D., Oliver K. L., Tuzun E., Damiano J. A., Ulusoy C., Andermann E., et al.
EPILEPSIA
, vol.59, no.8, 2018 (SCI-Expanded, Scopus)
2018
2018154. Effect of LGI1 antibody-positive IgG on hippocampal neuron survival: a preliminary study
Aysit-Altuncu N., Ulusoy C., ÖZTÜRK G., Tuzun E.
NEUROREPORT
, vol.29, no.11, pp.932-938, 2018 (SCI-Expanded, Scopus)
2018
2018155. Peripheral blood memory B cell frequency predicts conversion from clinically isolated syndrome to multiple sclerosis
Aktura S. D., Yilmaz V., Ozkan-Yasargun D., Ulusoy C., Tuzun E., Turkoglu R.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.23, pp.9-14, 2018 (SCI-Expanded, Scopus)
2018
2018156. Delta Brush Pattern Is Not Unique to NMDAR Encephalitis: Evaluation of Two Independent Long-Term EEG Cohorts
Baykan B., Tuncer O. G., Vanli-Yavuz E. N., Kirac L. B., Gundogdu G., Bebek N., et al.
CLINICAL EEG AND NEUROSCIENCE
, vol.49, no.4, pp.278-284, 2018 (SCI-Expanded)
2018
2018157. Prognostic Factors in Anti-Neurona Antibody Positive Patients
Aydin C., Celik S. Y., Icoz S., Ulusoy C. A., Gunduz T., Akman Demir G., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.55, no.2, pp.189-194, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
2018158. The psychiatric profiles of patients with temporal lobe epilepsy associated with neuronal auto-antibodies
Sezgin M., Cikrikcili U., Kulaksizoglu I. B., Vanli-Yavuz E. N., Bebek N., Tuzun E., et al.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, vol.35, no.2, pp.84-90, 2018 (SCI-Expanded)
2018
2018159. Mechanisms of action of intravenous immunoglobulin in septic encephalopathy
Esen F., Ozcan P. E., Tuzun E., Boone M. D.
REVIEWS IN THE NEUROSCIENCES
, vol.29, no.4, pp.417-423, 2018 (SCI-Expanded)
2018
2018160. Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels
Akcan U., Karabulut S., Kucukali C. I., Cakir S., Tuzun E.
ACTA NEUROPSYCHIATRICA
, vol.30, no.2, pp.70-78, 2018 (SCI-Expanded)
2018
2018161. Reduced Peripheral Blood Mononuclear Cell ROCK1 and ROCK2 Levels in Obstructive Sleep Apnea Syndrome
Aydin S., Ozdemir C., Kucukali C. I., Sokucu S. N., Giris M., Akcan U., et al.
IN VIVO
, vol.32, no.2, pp.319-325, 2018 (SCI-Expanded)
2018
2018162. Comparison of the expression of levels of PI3K/Akt pathway factors in Parkinson’s disease and lung cancer
Şanlı E., Yalçınkaya N., Tüzün E.
EXPERIMED
, vol.8, no.2, pp.52-57, 2018 (Peer-Reviewed Journal)
2018
2018163. Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis
TEZER FİLİK F. İ., FIRAT A., Tuzun E., Unal I., Soylemezoglu F., BİLGİNER B., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.128, no.5, pp.421-428, 2018 (SCI-Expanded)
2018
2018164. Transcriptional repressor Blimp1 regulates follicular regulatory T-cell homeostasis and function
Yang G., Yang X., Zhang J., Li G., Zheng D., Peng A., et al.
IMMUNOLOGY
, vol.153, no.1, pp.105-117, 2018 (SCI-Expanded)
2018
2018165. Chronic mild stress-induced anhedonia in rats is coupled with the upregulation of inflammasome sensors: a possible involvement of NLRP1
Ozkartal C. S., ARICIOĞLU F., Tuzun E., Kucukali C. I.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
, vol.28, no.3, pp.236-244, 2018 (SCI-Expanded)
2018
2018166. Effects of computer-assisted cognitive rehabilitation in benign multiple sclerosis
Arsoy E., Tuzun E., Turkoglu R.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.48, no.5, pp.999-1005, 2018 (SCI-Expanded)
2018
2018167. Immunopathological Factors Associated with Disability in Multiple Sclerosis.
Tüzün E.
Noro psikiyatri arsivi
, vol.55, no.Suppl 1, 2018 (SCI-Expanded)
2017
2017168. Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis.
Esen F., Orhun G., Ozcan P., Senturk E., KUCUKERDEN M., GIRIS M., et al.
Intensive care medicine experimental
, vol.5, pp.1, 2017 (ESCI, Scopus)
2017
2017169. Investigation of anti-neuronal antibodies in status epilepticus of unknown etiology: a prospective study
Atmaca M. M., Tuzun E., Erdag E., Bebek N., Baykan B., Gurses C.
ACTA NEUROLOGICA BELGICA
, vol.117, no.4, pp.841-848, 2017 (SCI-Expanded)
2017
2017170. A NMOSD case with multifocal nervous system involvement in a single attack
Tanyel T., Karaaslan Z., Misirli H., Gencer M., Tuzun E., Turkoglu R.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.18, pp.82-84, 2017 (SCI-Expanded)
2017
2017171. Investigation of DNA repair genes in patients with obsessive-compulsive disorder
Celik R., Iplik E. S., Kucukali C. İ., Tuzun E., Cakmakoglu B.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
, vol.26, no.8, pp.1269-1273, 2017 (SCI-Expanded)
2017
2017172. Glial and neuronal antibodies in patients with idiopathic intracranial hypertension
Altiokka-Uzun G., Erdag E., Baykan B., TZARTOS J., Gezen-Ak D., Samanci B., et al.
NEUROLOGICAL SCIENCES
, no.10, pp.1817-1822, 2017 (SCI-Expanded, Scopus)
2017
2017173. Anti-Neuronal Autoantibodies in Both Drug Responsive and Resistant Focal Seizures with Unknown Cause
Gozubatik-Celik G., Ozkara C., Ulusoy C. A., Gunduz A., Delil S., Yeni N., et al.
EPILEPSY RESEARCH
, vol.135, pp.131-136, 2017 (SCI-Expanded, Scopus)
2017
2017174. Impact of Topiramate on Rat Phrenic Nerve-Hemidiaphragm Preparations
Kucukali C. I., Tuzun E., NURTEN A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.54, no.3, pp.202-204, 2017 (SCI-Expanded)
2017
2017175. Neuron-specific enolase levels as a marker for possible neuronal damage in idiopathic intracranial hypertension
Samanci Y., Samanci B., Sahin E., Altiokka-Uzun G., Kucukali C. I., Tuzun E., et al.
ACTA NEUROLOGICA BELGICA
, vol.117, no.3, pp.707-711, 2017 (SCI-Expanded, Scopus)
2017
2017176. Recurrent tumefactive demyelinating lesions: a pathological study
Turkoglu R., Lassmann H., Aker F. V., Tzartos J., Tzartos S., Tuzun E.
CLINICAL NEUROPATHOLOGY
, vol.36, no.4, pp.195-198, 2017 (SCI-Expanded)
2017
2017177. Investigation of the prognostic value of adipokines in multiple sclerosis
Coban A., Duzel B., Tuzun E., Tamam Y.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.15, pp.11-14, 2017 (SCI-Expanded)
2017
2017178. Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis
Giris M., Durmus H., Yetimler B., Tasli H., Parman Y., Tuzun E.
IN VIVO
, no.4, pp.657-660, 2017 (SCI-Expanded, Scopus)
2017
2017179. Clinical, Electrophysiological, and Serological Evaluation of Patients with Cramp-Fasciculation Syndrome
Poyraz M., Matur Z., Aysal F., Tuzun E., Hanoglu L., Oge A. E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.54, no.2, pp.183-186, 2017 (SCI-Expanded)
2017
2017180. Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG
Erdag E., Sahin C., Kucukali C. İ., Bireller S., Kucukerden M., Kurtuncu M., et al.
NEUROLOGICAL SCIENCES
, no.5, pp.833-843, 2017 (SCI-Expanded)
2017
2017181. Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension
Samanci B., Samancı Y., Tuzun E., Altiokka-Uzun G., Ekizoglu E., Icoz S., et al.
CEPHALALGIA
, vol.37, no.6, pp.525-531, 2017 (SCI-Expanded, Scopus)
2017
2017182. Neurodegenerative diseases and SUMO
Ay U., Şen M., Akbayır E., Tüzün E., Küçükali C. İ.
EXPERIMED , vol.7, no.13, pp.59-70, 2017 (Peer-Reviewed Journal)
2017
2017183. VIABILITY OF SH-SY5Y CELLS IS ASSOCIATED WITH PURINERGIC P2 RECEPTOR EXPRESSION ALTERATIONS
Orcen A., Yilmaz V., Giris M., Akcan U., Tuzun E., Erten G.
ACTA BIOLOGICA HUNGARICA
, vol.68, no.1, pp.22-34, 2017 (SCI-Expanded)
2017
2017184. Etiopathogenesis of Parkinson’s disease
Akbayır E., Şen M., Ay U., Şenyer S., Tüzün E., Küçükali C. İ.
EXPERIMED , vol.7, no.13, pp.1-23, 2017 (Peer-Reviewed Journal)
2017
2017185. Impact of Neuro-Behcet Disease Immunoglobulin G on Neuronal Apoptosis
Giris M., Bireller S., Kucukali C. I., Hanagasi H. A., Degirmencioglu S., Tuzun E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.54, no.1, pp.67-71, 2017 (SCI-Expanded)
2017
2017186. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
Wu X., Tuzun E.
MEDICAL HYPOTHESES
, vol.99, pp.26-28, 2017 (SCI-Expanded)
2017
2017187. Neuronal nitric oxide synthase polymorphisms in obsessive-compulsive disorder
TOPALOGLU M., Tuzun E., GULEC H., Bireller E. S., Cakmakoglu B., Kucukali C. İ.
NORDIC JOURNAL OF PSYCHIATRY
, vol.71, no.2, pp.115-119, 2017 (SCI-Expanded)
2017
2017188. A Case of Seronegative Limbic Encephalitis with Multiple Sclerosis: A Possible Overlapping Syndrome
Karaaslan Z., Mercan O., Tuzun E., Misirli H., Turkoglu R.
AMERICAN JOURNAL OF CASE REPORTS
, vol.18, pp.64-66, 2017 (ESCI)
2017
2017189. Investigation of neuronal auto-antibodies in systemic lupus erythematosus patients with epilepsy
Karaaslan Z., Ekizoglu E., Tekturk P., Erdag E., Tuzun E., Bebek N., et al.
EPILEPSY RESEARCH
, pp.132-137, 2017 (SCI-Expanded)
2017
2017190. Agmatine produces antidepressant effect via modulation of neuroinflammation in chronic unpredictable mild stress model of rats: Implication in inflammatory perspective of depression
Şahin-Özkartal C., Arıcıoğlu F., Tüzün E., Keleş R., Kandemir C., Şirvancı S., et al.
Psychiatry and Clinical Psychopharmacology , vol.27, no.1, pp.184-188, 2017 (Peer-Reviewed Journal)
2017
2017191. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice
Ulusoy C. A., Cavus F., Yilmaz V., Tuzun E.
IMMUNOLOGICAL INVESTIGATIONS
, vol.46, no.5, pp.490-499, 2017 (SCI-Expanded, Scopus)
2017
2017192. The role of NF-B in neuronal plasticity and neurodegenerative diseases
Yağmur E., Yıldız N., Adıgüzel S., Femir B., Şenyer S., Şen M., et al.
EXPERIMED , vol.7, no.13, pp.71-85, 2017 (Peer-Reviewed Journal)
2017
2017193. NF-B, SUMO and ubiquitination relationship
Şen M., Ay U., Akbayır E., Şenyer S., Tüzün E., Küçükali C. İ.
EXPERIMED , vol.7, no.13, pp.35-46, 2017 (Peer-Reviewed Journal)
2017
2017194. The antibody and cytokine profile in MuSK-associated myasthenia gravis
Yüceer Korkmaz H., Ulusoy C. A., Tüzün E.
EXPERIMED , vol.7, no.14, pp.39-49, 2017 (Peer-Reviewed Journal)
2017
2017195. The role of DNA repair mechanisms in neurodegenerative diseases
Şen M., Ay U., Tüzün E., Küçükali C. İ.
EXPERIMED , vol.7, no.13, pp.47-58, 2017 (Peer-Reviewed Journal)
2016
2016196. Brain Infiltration of Immune Cells in CASPR2-Antibody Associated Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
Unverengil G., Vanli Yavuz E. N., Tuzun E., Erdag E., Kabadayi S., Bilgic B., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.53, no.4, pp.344-347, 2016 (SCI-Expanded)
2016
2016197. NMDA receptor encephalitis with cancer of unknown primary origin
Çoban A., GÜNDOGDU G., Poyraz M., Yegen G., DEMIRTAŞ-TATLIDEDE A., Bilgiç B., et al.
TUMORI
, vol.102, 2016 (SCI-Expanded, Scopus)
2016
2016198. 36th International Symposium on Intensive Care and Emergency Medicine
Orhun G., Şentürk E., Ergin Özcan P., Sencer N. S., Ulusoy C. A., Tüzün E., et al.
Critical Care , vol.20, pp.347, 2016 (Peer-Reviewed Journal)
2016
2016199. Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder
Tokaç D., Tuzun E., GULEC H., Yilmaz V., Bireller E. S., Cakmakoglu B., et al.
PSYCHIATRY INVESTIGATION
, vol.13, no.5, pp.541-548, 2016 (SCI-Expanded)
2016
2016200. Reduced fecal GABA levels in multiple sclerosis patients
Yalcinkaya N., Akcan U., Orcen A., Kucukali C. İ., Tuzun E., TURKOGLU R., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, pp.60-61, 2016 (SCI-Expanded)
2016
2016201. Expression of switch-associated protein 70 is associated with lymphocyte activation and reduced disability in multiple sclerosis
Türkoğlu R., özyurt S., Ulusoy C. A., ERDAG E., Tuzun E.
IMMUNOLOGY LETTERS
, vol.177, pp.75-77, 2016 (SCI-Expanded, Scopus)
2016
2016202. Chemokine gene variants in schizophrenia
Dasdemir S., Kucukali C. I., Bireller E. S., Tuzun E., Cakmakoglu B.
NORDIC JOURNAL OF PSYCHIATRY
, vol.70, no.6, pp.407-412, 2016 (SCI-Expanded)
2016
2016203. Are There Any Specific EEG Findings in Autoimmune Epilepsies?
Baysal-Kirac L., Tuzun E., ALTINDAG E., Ekizoglu E., KINAY D., Bilgic B., et al.
CLINICAL EEG AND NEUROSCIENCE
, no.3, pp.224-234, 2016 (SCI-Expanded)
2016
2016204. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis
Vanli-Yavuz E. N., Erdag E., Tuzun E., Ekizoglu E., Baysal-Kirac L., Ulusoy C. A., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, vol.87, no.7, pp.684-692, 2016 (SCI-Expanded, Scopus)
2016
2016205. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
Oeckl P., Jardel C., Salachas F., Lamari F., Andersen P. M., Bowser R., et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION
, vol.17, pp.404-413, 2016 (SCI-Expanded)
2016
2016206. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK
Kucukerden M., Huda R., Tuzun E., Yilmaz A., Skriapa L., Trakas N., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.295, pp.84-92, 2016 (SCI-Expanded)
2016
2016207. Neuronal autoantibodies in patients with Rasmussen's encephalitis
Samanci B., Tekturk P., Tuzun E., Erdag E., KINAY D., Yapici Z., et al.
EPILEPTIC DISORDERS
, no.2, pp.204-210, 2016 (SCI-Expanded, Scopus)
2016
2016208. The Owner and Responsible Manager on behalf of Turkish Neuropsychiatric Society (President)
Atbasoglu E. C., Tuzun E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.53, no.2, 2016 (SCI-Expanded)
2016
2016209. Behcet's Disease and Nervous System Involvement
Kurtuncu M., Tuzun E., AKMAN-DEMIR G.
CURRENT TREATMENT OPTIONS IN NEUROLOGY
, vol.18, no.5, 2016 (SCI-Expanded)
2016
2016210. Autoantibodies to Neurotransmitter Receptors and Ion Channels in Psychotic Disorders
Tuzun E.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
, vol.26, no.1, pp.75-82, 2016 (SCI-Expanded)
2016
2016211. Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings
Baysal-Kirac L., Tuzun E., Erdag E., Ulusoy C., Vanli-Yavuz E. N., Ekizoglu E., et al.
JOURNAL OF NEUROLOGY
, vol.263, no.3, pp.455-466, 2016 (SCI-Expanded)
2016
2016212. First-episode psychotic disorder improving after immunotherapy
Gungor I., Derin S., Tekturk P., Tuzun E., Bilgic B., Cakir S.
ACTA NEUROLOGICA BELGICA
, vol.116, no.1, pp.113-114, 2016 (SCI-Expanded)
2016
2016213. Increased complexin-1 and decreased miR-185 expression levels in Beh‡et's disease with and without neurological involvement
Ugurel E., Sehitoglu E., Tuzun E., Kurtuncu M., Coban A., Vural B.
NEUROLOGICAL SCIENCES
, no.3, pp.411-416, 2016 (SCI-Expanded)
2016
2016214. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease
Yalcinkaya N., Haytural H., Bilgic B., Ozdemir O., Hanagasi H. A., Kucukali C. I., et al.
NEUROSCIENCE LETTERS
, vol.615, pp.72-77, 2016 (SCI-Expanded, Scopus)
2016
2016216. Voltage-Gated Potassium Channel Antibodies is a Sign of Limbic Encephalitis
Bican Demir A., Uzun P., TAŞKAPILIOĞLU Ö., Bora I., Tuzun E.
EPILEPSI
, vol.22, pp.72-75, 2016 (ESCI)
2016
2016217. Association Between Polymorphisms of DNA Repair Genes and Risk of Schizophrenia
ODEMIS S., Tuzun E., GULEC H., SEMIZ U. B., Dasdemir S., Kucuk M., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, no.1, pp.11-17, 2016 (SCI-Expanded)
2016
2016218. Obturator mononeuropathy due to adenocarcinoma of unknown primary origin
TURKOGLU R., GENCER M., AKER F. V., MERIC K., GOKCEER S. Y., Coban A., et al.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
, no.6, pp.882-883, 2016 (SCI-Expanded)
2016
2016219. Limbic Encephalitis Associated with Sjogren's Syndrome: Report of Three Cases
Coban A., Ozyurt S., Meric K., Misirli H., Tuzun E., Turkoglu R.
INTERNAL MEDICINE
, vol.55, no.16, pp.2285-2289, 2016 (SCI-Expanded)
2016
2016220. Epilepsy and Autoimmunity: Basic Physiopathological Mechanisms
Vanli Yavuz E. N., Tuzun E.
EPILEPSI
, vol.22, pp.1-6, 2016 (ESCI)
2016
2016221. Anti-Neuronal Autoantibodies Associated with Epilepsy and Related Neurological Syndromes
Coban A., Tuzun E.
EPILEPSI
, vol.22, pp.7-13, 2016 (ESCI)
2015
2015222. Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.
Ulusoy C. A., Zibandeh N., Yildirim S., TRAKAS N., ZISIMOPOULOU P., Kucukerden M., et al.
Journal of neuroinflammation
, vol.12, pp.231, 2015 (SCI-Expanded, Scopus)
2015
2015223. Ocular myasthenia gravis induced by human acetylcholine receptor epsilon subunit immunization in HLA DR3 transgenic mice
WU X., Tuzun E., SAINI S. S., WANG J., LI J., AGUILERA-AGUIRRE L., et al.
IMMUNOLOGY LETTERS
, vol.168, no.2, pp.306-312, 2015 (SCI-Expanded)
2015
2015224. Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice.
Ozkok E., Durmus H., Yetimler B., Tasli H., TRAKAS N., Ulusoy C. A., et al.
Clinical neuropathology
, vol.34, no.6, pp.359-63, 2015 (SCI-Expanded, Scopus)
2015
2015225. Behcet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria
AKMAN-DEMIR G., Mutlu M. O., KIYAT-ARAMER A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, vol.33, no.6, 2015 (SCI-Expanded)
2015
2015226. Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension
Altiokka-Uzun G., Tuzun E., Ekizoglu E., Ulusoy C. A., Yentur S., Kurtuncu M., et al.
CEPHALALGIA
, no.13, pp.1153-1161, 2015 (SCI-Expanded, Scopus)
2015
2015227. A case of hyperkinetic movement disorder associated with LGI1 antibodies
Erer-Ozbek S., Yapici Z., Tuzun E., Giris M., Duran S., Taskapilioglu O., et al.
TURKISH JOURNAL OF PEDIATRICS
, vol.57, no.5, pp.514-517, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
2015228. The association between obesity and oligoclonal band formation in multiple sclerosis patients
Coban A., çevik D., özyurt S., Gencer M., Tuzun E., TURKOGLU R.
OBESITY RESEARCH & CLINICAL PRACTICE
, no.5, pp.533-535, 2015 (SCI-Expanded)
2015
2015229. Reduced serum vitamin D levels in neuromyelitis optica
Tuzun E., Kucukhuseyin Ö., Kurtuncu M., TURKOGLU R., Yaylim I.
NEUROLOGICAL SCIENCES
, no.9, pp.1701-1702, 2015 (SCI-Expanded)
2015
2015230. Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization
Tuzun E., BERRIH-AKNIN S., Brenner T., Kusner L. L., LE PANSE R., YANG H., et al.
EXPERIMENTAL NEUROLOGY
, vol.270, pp.11-17, 2015 (SCI-Expanded)
2015
2015231. Epigenetics of Multiple Sclerosis: An Updated Review
Kucukali C. İ., Kurtuncu M., Coban A., Cebi M., Tuzun E.
NEUROMOLECULAR MEDICINE
, no.2, pp.83-96, 2015 (SCI-Expanded)
2015
2015232. Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients
Erdag E., ÇELEBİSOY N., YÜCEYAR A. N., Kurtuncu M., Vural B., Tuzun E.
ACTA NEUROLOGICA BELGICA
, vol.115, no.2, pp.137-140, 2015 (SCI-Expanded)
2015
2015233. Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis
PETEK-BALCI B., Coban A., Shugaiv E., TURKOGLU R., Ulusoy C., Icoz S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.5, pp.352-356, 2015 (SCI-Expanded, Scopus)
2015
2015234. Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK
Yilmaz V., Oflazer P., AYSAL F., Durmus H., Poulas K., Yentur S. P., et al.
PLoS ONE
, vol.10, no.4, 2015 (SCI-Expanded, Scopus)
2015
2015235. IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice
HUDA R., STRAIT R. T., Tuzun E., FINKELMAN F. D., CHRISTADOSS P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.281, pp.68-72, 2015 (SCI-Expanded)
2015
2015236. Peripheral nerve hyperexcitability syndromes
Kucukali C. İ., Kurtuncu M., Akcay H. I., Tuzun E., Oge A. E.
REVIEWS IN THE NEUROSCIENCES
, no.2, pp.239-251, 2015 (SCI-Expanded)
2015
2015237. Inflammation and autoimmunity in epilepsy pathogenesis
Vanlı Yavuz E. N., Tüzün E., Baykan B.
EXPERIMED , vol.3, no.9, pp.7-14, 2015 (Peer-Reviewed Journal)
2015
2015238. Evaluation of Paraoxonase 1 Polymorphisms in Patients with Bipolar Disorder
Kucukali C. İ., Ulusoy C., OZKAN O., Orhan N., GULEC H., Erdag E., et al.
IN VIVO
, vol.29, no.1, pp.103-108, 2015 (SCI-Expanded, Scopus)
2015
2015239. Febrile Infection Related Epilepsy Syndrome (FIRES) in Adults Imitating Limbic Encephalitis
Tekturk P., Baykan B., Tuzun E.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, vol.32, no.1, pp.243-249, 2015 (SCI-Expanded)
2015
2015240. Uveitis as a prognostic factor in multiple sclerosis
Shugaiv E., Tuzun E., Kurtuncu M., Kiyat-Atamer A., Coban A., Akman-Demir G., et al.
MULTIPLE SCLEROSIS JOURNAL
, no.1, pp.105-107, 2015 (SCI-Expanded)
2014
2014241. Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients
Kucukali C. İ., Haytural H., Benbir G., Coban A., Ulusoy C., Giris M., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES
, no.1-2, pp.353-355, 2014 (SCI-Expanded, Scopus)
2014
2014242. Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study
Sehitoglu E., Cavus F., Ulusoy C., Kucukerden M., Orcen A., Akbas-Demir D., et al.
INFLAMMATION RESEARCH
, no.10, pp.799-801, 2014 (SCI-Expanded, Scopus)
2014
2014243. Guillain-Barre Syndrome in a Patient with Primary Extranodal Intestinal Non-Hodgkin's Lymphoma: Paraneoplastic, Drug Induced or Coincidental?
Atamer A. K., Okutur K., Tuzun E., Hasbal B., BOYACIYAN A., Krespi Y., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.51, no.3, pp.288-292, 2014 (SCI-Expanded)
2014
2014244. Targeting complement system to treat myasthenia gravis
HUDA R., Tuzun E., CHRISTADOSS P.
REVIEWS IN THE NEUROSCIENCES
, vol.25, no.4, pp.575-583, 2014 (SCI-Expanded)
2014
2014245. The relationship between mitochondrial, oxidative, apoptotic parameters and PI3K/Akt pathway in animal model of Parkinson’s disease
Haytural H., Tüzün E.
EXPERIMED , vol.3, no.7, pp.28-37, 2014 (Peer-Reviewed Journal)
2014
2014246. Calcium channel antibodies in patients with absence epilepsy
Tekturk P., Baykan B., Ekizoglu E., Ulusoy C., Aydin-Ozemir Z., Icoz S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.124, no.7, pp.486-490, 2014 (SCI-Expanded, Scopus)
2014
2014247. Increased IL-23 receptor, TNF-alpha and IL-6 expression in individuals with the IL23R-IL12R132 locus polymorphism
Cavus F., Ulusoy C., Orcen A., Gül A., Tuzun E., Vural B.
IMMUNOLOGY LETTERS
, vol.160, no.1, pp.96-98, 2014 (SCI-Expanded, Scopus)
2014
2014248. Anti NMDA receptor encephalitis associated with thymic hyperplasia: A case report
Yilmaz B., Mastanzade T., Ozkara C., Erkol O., Tuzun E.
NEUROLOGY INDIA
, vol.62, no.3, pp.331-332, 2014 (SCI-Expanded)
2014
2014249. Encephalomyelitis
Tüzün E.
Türkiye Klinikleri Journal of Medical Research , vol.7, no.3, pp.26-31, 2014 (Peer-Reviewed Journal)
2014
2014250. Pathogenesis of paraneoplastic neurological syndromes
Tüzün E., Akman Demir G.
Türkiye Klinikleri Journal of Medical Research , vol.7, no.3, pp.4-14, 2014 (Peer-Reviewed Journal)
2014
2014251. Investigation of neuronal autoantibodies in two different focal epilepsy syndromes
Ekizoglu E., Tuzun E., Woodhall M., Lang B., Jacobson L., Icoz S., et al.
EPILEPSIA
, vol.55, no.3, pp.414-422, 2014 (SCI-Expanded)
2014
2014252. Evaluation of incidence and clinical features of antibody-Associated autoimmune encephalitis mimicking dementia
Coban A., Kucukali C. I., Bilgic B., Yalcinkaya N., Haytural H., Ulusoy C., et al.
Behavioural Neurology
, vol.2014, 2014 (SCI-Expanded, Scopus)
2014
2014253. Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression
TURKOGLU R., Gencer M., EKMEKCI D., Ulusoy C., Erdag E., Sehitoglu E., et al.
MEDICAL PRINCIPLES AND PRACTICE
, no.3, pp.239-245, 2014 (SCI-Expanded, Scopus)
2014
2014254. Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice
Ulusoy C. A., KIM E., Tuzun E., HUDA R., Yilmaz V., Poulas K., et al.
Clinical Immunology
, vol.151, no.2, pp.155-163, 2014 (SCI-Expanded, Scopus)
2014
2014255. Aquaporin-1 Antibody in Neuromyelitis Optica Patients
Tuzun E., TZARTOS J., Ekizoglu E., STERGIOU C., ZISIMOPOULOU P., Coban A., et al.
EUROPEAN NEUROLOGY
, no.5-6, pp.271-272, 2014 (SCI-Expanded)
2013
2013256. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica
Woodhall M., Coban A., Waters P., Eldzoglu E., Kurtuncu M., Shugaiv E., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES
, no.1-2, pp.221-223, 2013 (SCI-Expanded)
2013
2013257. Expression analysis and clinical correlation of aquaporin 1 and 4 genes in human hippocampal sclerosis
Bebek N., Özdemir Ö., Sayitoglu M., Hatirnaz O., Baykan B., Gurses C., et al.
JOURNAL OF CLINICAL NEUROSCIENCE
, vol.20, no.11, pp.1564-1570, 2013 (SCI-Expanded)
2013
2013258. GUILLAIN-BARRE-LIKE SYNDROME ASSOCIATED WITH LUNG ADENOCARCINOMA AND CASPR2 ANTIBODIES
Tuzun E., Kinay D., Hacohen Y., Aysal F., Vincent A.
MUSCLE & NERVE
, vol.48, no.5, pp.836-837, 2013 (SCI-Expanded)
2013
2013259. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behcet's disease
Vural B., Sehitoglu E., Cavus F., Yalcinkaya N., Haytural H., Kucukerden M., et al.
JOURNAL OF NEUROIMMUNOLOGY
, no.1-2, pp.139-144, 2013 (SCI-Expanded, Scopus)
2013
2013260. Reduced Orexin-A Levels in Frontotemporal Dementia: Possible Association With Sleep Disturbance
Coban A., Bilgic B., Lohmann E., Kucukali C. I., Benbir G., Karadeniz D., et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS
, vol.28, no.6, pp.606-611, 2013 (SCI-Expanded, Scopus)
2013
2013261. Experimental autoimmune myasthenia gravis in the mouse
Wu B., Goluszko E., Huda R., TÜZÜN E., Christadoss P.
Current Protocols in Immunology
, no.SUPPL.100, 2013 (Scopus)
2013
2013262. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis
Coban A., Ulusoy C. A., Giris M., Turan S., TUERKOGLU R., Tuzun E., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.8, pp.557-562, 2013 (SCI-Expanded, Scopus)
2013
2013263. Non-Convulsive Status Epilepticus Associated With Glutamic Acid Decarboxylase Antibody
Cikrikcili U., Ulusoy C. A., Turan S., Yildiz S., Bilgic B., Hanagasi H. A., et al.
CLINICAL EEG AND NEUROSCIENCE
, vol.44, no.3, pp.232-236, 2013 (SCI-Expanded, Scopus)
2013
2013264. Impact of cigarette smoking on conversion from clinically isolated syndrome to clinically definite multiple sclerosis
Arikanoglu A., Shugaiv E., Tuzun E., Erakso M.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.123, no.7, pp.476-479, 2013 (SCI-Expanded)
2013
2013265. Complement associated pathogenic mechanisms in myasthenia gravis
Tuzun E., CHRISTADOSS P.
AUTOIMMUNITY REVIEWS
, vol.12, no.9, pp.904-911, 2013 (SCI-Expanded)
2013
2013266. Complement C2 siRNA mediated therapy of myasthenia gravis in mice
HUDA R., Tuzun E., CHRISTADOSS P.
JOURNAL OF AUTOIMMUNITY
, vol.42, pp.94-104, 2013 (SCI-Expanded)
2013
2013267. Peripheral Neuropathy Associated With Antiglutamic Acid Decarboxylase Antibodies
Saltik S., Turkes M., Tuzun E., Cakir A., Ulusoy C.
PEDIATRIC NEUROLOGY
, vol.48, no.5, pp.403-406, 2013 (SCI-Expanded, Scopus)
2013
2013268. Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients
KIYAT-ATAMER A., Ekizoglu E., Tuzun E., Kurtuncu M., Shugaiv E., AKMAN-DEMIR G., et al.
EUROPEAN JOURNAL OF NEUROLOGY
, no.5, pp.781-787, 2013 (SCI-Expanded)
2013
2013269. Coexistence of Guillain-Barre syndrome and Behcet's disease
Shugaiv E., Kiyat-Atamer A., Tuzun E., Deymeer F., Oflazer P., Parman Y., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, no.3, 2013 (SCI-Expanded)
2013
2013270. Aquaporin-4 antibody seropositivity in myasthenia gravis patients with thymoma
Ekizoglu E., Yilmaz V., Icoz S., Birisik O., Tuzun E., Akman-Demir G., et al.
Muscle and Nerve
, vol.47, no.2, pp.306-307, 2013 (SCI-Expanded)
2013
2013271. Kleptomania in Patients with Neuro-Behcet's Disease
Shugaiv E., Kiyat-Atamer A., Tuzun E., Kurtuncu M., Baral-Kulaksizoglu I., Demir G. A.
MEDICAL PRINCIPLES AND PRACTICE
, no.6, pp.550-554, 2013 (SCI-Expanded)
2013
2013272. Epilepsy and Autoimmunity
ÇOBAN A., EKİZOĞLU TURGUT E., TÜZÜN E.
EPILEPSI
, vol.19, no.2, pp.39-47, 2013 (ESCI)
2013
2013273. Anti-N-methyl-D-aspartate receptor encephalitis with minimal cortical impairment
Tuzun E., TURKOGLU R., Yumerhodzha S. M., Erdag E., Eraksoy M., Akman-Demir G.
NEUROLOGICAL SCIENCES
, vol.34, no.1, pp.111-113, 2013 (SCI-Expanded)
2013
2013274. CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL)
Kurtuncu M., KAYA D., Zuliani L., Erdag E., Icoz S., Ugurel E., et al.
CEPHALALGIA
, vol.33, no.2, pp.123-129, 2013 (SCI-Expanded)
2013
2013275. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures
Durmus H., Kurtuncu M., Tuzun E., Pehlivan M., Akman-Demir G., Yapici Z., et al.
Acta Neurologica Belgica
, vol.113, no.4, pp.421-426, 2013 (SCI-Expanded, Scopus)
2013
2013276. Syndrome of Headache Accompanied with Transient Neurologic Deficits and Cerebrospinal Fluid Lymphocytosis
Coban A., Shugaiv E., Tuzun E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, pp.52-55, 2013 (SCI-Expanded)
2013
2013277. Progressive Encephalomyelitis with Rigidity and Myoclonus: A Syndrome with Diverse Clinical Features and Antibody Responses
Shugaiv E., Leite M. I., Sehitoglu E., Woodhall M., Cavus F., Waters P., et al.
EUROPEAN NEUROLOGY
, no.5, pp.257-262, 2013 (SCI-Expanded, Scopus)
2012
2012278. Isolated dysphagia due to aquaporin-4 autoimmunity
TURKOGLU R., Kiyat-Atamer A., Tuzun E., Akman-Demir G.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.23, no.6, pp.804-805, 2012 (SCI-Expanded)
2012
2012279. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.
Tuezuen E., ALLMAN W., Ulusoy C. A., YANG H., CHRISTADOSS P.
Annals of the New York Academy of Sciences
, vol.1274, pp.133-9, 2012 (SCI-Expanded, Scopus)
2012
2012280. Cognitive Impairment in Neuro-Behcet's Disease and Multiple Sclerosis: A Comparative Study
Gunduz T., Emir O., Kurtuncu M., Mutlu M., Tumac A., Akca S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.11, pp.650-656, 2012 (SCI-Expanded, Scopus)
2012
2012281. Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse
Erdag E., Tuzun E., Ugurel E., Cavus F., Sehitoglu E., Giris M., et al.
INFLAMMATION RESEARCH
, vol.61, no.9, pp.927-930, 2012 (SCI-Expanded)
2012
2012282. CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis
ALLMAN W., QI H., SAINI S. S., LI J., Tuzun E., CHRISTADOSS P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.249, pp.1-7, 2012 (SCI-Expanded)
2012
2012283. Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23
Kurtuncu M., Tuzun E., TURKOGLU R., PETEK-BALCI B., Icoz S., Pehlivan M., et al.
CYTOKINE
, vol.59, no.2, pp.400-402, 2012 (SCI-Expanded, Scopus)
2012
2012284. Evaluation of Glutathione S-Transferase P1 Polymorphisms (Ile105Val and Ala114Val) in Patients with Small Cell Lung Cancer
Vural B., Yakar F., Derin D., Saip P., Yakar A., Demirkan A., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, vol.16, no.7, pp.701-706, 2012 (SCI-Expanded, Scopus)
2012
2012285. Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: Favorable response to cancer treatment
Armagan H., Tuzun E., Icoz S., Birisik O., Ulusoy C., Demir G., et al.
JOURNAL OF SPINAL CORD MEDICINE
, vol.35, no.4, pp.267-269, 2012 (SCI-Expanded, Scopus)
2012
2012286. Comparison of the Cytokine Profiles of Patients With Neuronal-Antibody-Associated Central Nervous System Disorders
Ulusoy C., Tuzun E., Kurtuncu M., TURKOGLU R., Akman-Demir G., Eraksoy M.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.6, pp.284-289, 2012 (SCI-Expanded, Scopus)
2012
2012287. Investigation of Swap70 antibody in patients with Behcet’s disease
Uğurel E., Karabulut A., Gül A., Güre A., Shugaiv E., Tüzün E., et al.
EXPERIMED , vol.2, no.4, pp.22-29, 2012 (Peer-Reviewed Journal)
2012
2012288. Prevalence of glutamic acid decarboxylase antibody in autoimmune encephalitis and its clinical spectrum
Ulusoy C. A., Turan S., Tüzün E.
EXPERIMED , vol.2, no.3, pp.23-27, 2012 (Peer-Reviewed Journal)
2012
2012289. Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension
Ekizoglu E., Icoz S., Tuzun E., Birisik O., Kocasoy-Orhan E., Akman-Demir G., et al.
CEPHALALGIA
, vol.32, no.3, pp.198-202, 2012 (SCI-Expanded)
2012
2012290. Ocular and generalized myasthenia gravis induced by human acetylcholine receptor ? subunit immunization
WU X., Tuzun E., LI J., XIAO T., SAINI S. S., QI H., et al.
MUSCLE & NERVE
, vol.45, no.2, pp.209-216, 2012 (SCI-Expanded)
2011
2011291. The Role of B Cells in Multiple Sclerosis Pathogenesis and Monoclonal Antibody Treatments Targeting B Cells
Tuzun E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.48, pp.73-78, 2011 (SCI-Expanded)
2011
2011292. Experimental autoimmune myasthenia gravis in the mouse.
Wu B., Goluszko E., Huda R., Tüzün E., Christadoss P.
Current protocols in immunology
, no.15, 2011 (Scopus)
2011
2011293. Increased complement consumption in musk-antibody-positive myasthenia gravis patients
Tuzun E., Yilmaz V., Parman Y., Oflazer P., Deymee F., Saruhan-Direskeneli G.
Medical Principles and Practice
, vol.20, no.6, pp.581-583, 2011 (SCI-Expanded)
2011
2011294. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behcet's disease
Vural B., Ugurel E., Tuzun E., Kurtuncu M., Zuliani L., Cavus F., et al.
JOURNAL OF NEUROIMMUNOLOGY
, no.1-2, pp.91-97, 2011 (SCI-Expanded)
2011
2011295. Complement and cytokine based therapeutic strategies in myasthenia gravis
Tuezuen E., Huda R., Christadoss P.
JOURNAL OF AUTOIMMUNITY
, vol.37, no.2, pp.136-143, 2011 (SCI-Expanded)
2011
2011296. Increased Alcohol Consumption Rates of Multiple Sclerosis Patients and Their Parents
Pehlivan M., Kurtuncu M., Yargic I., Tuzun E.
AMERICAN JOURNAL ON ADDICTIONS
, vol.20, no.5, pp.488-489, 2011 (SSCI)
2011
2011297. Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis
ALLMAN W., SAINI S. S., Tuzun E., CHRISTADOSS P.
Cellular Immunology
, vol.271, no.2, pp.292-298, 2011 (SCI-Expanded)
2011
2011298. Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behcet's disease with parenchymal involvement: presentation of four cases
Shugaiv E., Tuzun E., Mutlu M. O., Kiyat-Atamer A., Kurtuncu M., Akman-Demir G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, no.4, 2011 (SCI-Expanded)
2011
2011299. The comparison of socio-economic conditions and personal hygiene habits of neuro-Behcet's disease and multiple sclerosis patients
Pehlivan M., Kurtuncu M., Tuzun E., Shugaiv E., Mutlu M., Eraksoy M., et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
, vol.214, no.4, pp.335-337, 2011 (SCI-Expanded)
2011
2011300. Steroid-responsive recurrent limbic encephalitis associated with small cell lung cancer and neuropil antibodies
Tuzun E., Yaka E., Zuliani L., Icoz S., Baklan B., Birisik O., et al.
ACTA NEUROLOGICA BELGICA
, vol.111, no.2, pp.139-142, 2011 (SCI-Expanded)
2011
2011301. Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis
QI H., LI J., ALLMAN W., SAINI S. S., Tuezuen E., WU X., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.234, pp.165-167, 2011 (SCI-Expanded)
2011
2011302. Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients
Tuzun E., Kurtuncu M., TURKOGLU R., Icoz S., Pehlivan M., Birisik O., et al.
JOURNAL OF NEUROIMMUNOLOGY
, no.1-2, pp.211-215, 2011 (SCI-Expanded)
2011
2011303. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients
Akman-Demir G., Tuzun E., Waters P., Icoz S., Kurtuncu M., Jarius S., et al.
JOURNAL OF NEUROLOGY
, no.3, pp.464-470, 2011 (SCI-Expanded)
2011
2011304. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis
Tuzun E., Erdag E., Durmus H., Brenner T., Turkoglu R., Kurtuncu M., et al.
NEUROLOGY INDIA
, vol.59, no.1, pp.47-50, 2011 (SCI-Expanded, Scopus)
2011
2011305. Seizures associated with amphiphysin antibody
Tüzün E., Bebek N., Gürses R. C., Akman-Demir G., Gökyiğit A.
Mediterranean Oncology Journal , vol.1, no.1, pp.52-53, 2011 (Peer-Reviewed Journal)
2011
2011306. Association of systemic autoantibody positivity with the presence of oligoclonal bands and disability in multiple sclerosis
Tüzün E., Türkoğlu R.
EXPERIMED , vol.1, no.1, pp.34-39, 2011 (Peer-Reviewed Journal)
2011
2011307. Antineuronal Antibodies in Migraine Patients With White Matter Lesions
TURKOGLU R., Tuzun E., Icoz S., Birisik O., Erdag E., Kurtuncu M., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.1, pp.33-36, 2011 (SCI-Expanded)
2010
2010308. Bickerstaff's encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies
Tuzun E., Kurtuncu M., Lang B., Icoz S., Akman-Demir G., Eraksoy M., et al.
EUROPEAN JOURNAL OF NEUROLOGY
, no.10, pp.1304-1307, 2010 (SCI-Expanded)
2010
2010309. Unihemispheric acute disseminated encephalomyelitis: A case report Tek hemisferi tutan akut dissemine ensefalomiyelit: Olgu sunumu
Durmus H., TURKOGLU R., Tuzun E.
Noropsikiyatri Arsivi
, vol.47, no.2, pp.166-168, 2010 (SCI-Expanded)
2010
2010310. Amphiphysin Autoimmunity: Associated Neurological Syndromes and Tumors in The Turkish Population
Tuzun E., Bebek N., Icoz S., Durmus H., Kurtuncu M., Gurses C., et al.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, vol.27, no.2, pp.121-126, 2010 (SCI-Expanded, TRDizin)
2010
2010311. Steroid-Responsive Myeloneuropathy Associated With Antithyroid Antibodies
TURKOGLU R., Tuzun E.
JOURNAL OF SPINAL CORD MEDICINE
, vol.33, no.3, pp.278-280, 2010 (SCI-Expanded)
2010
2010312. A rare case of multiple sclerosis and cerebral hemorrhage associated with osteopetrosis
KAYA D., Tüzün E., DİNÇER A., PAMİR M. N., Kürtüncü M.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY
, no.1, pp.16-19, 2010 (SCI-Expanded)
2010
2010313. Peripheral nerve hyperexcitability syndromes
Tüzün E., Öge A. E.
Türkiye Klinikleri Journal of Medical Research , vol.3, no.2, pp.91-98, 2010 (Peer-Reviewed Journal)
2010
2010314. Erdheim-Chester disease presented with bilateral carotid artery occlusion: Case Report
Çelik Y., Balcı K., Asil T., Tüzün E., Hamamcioglu M., Temizöz O., et al.
TURK NOROLOJI DERGISI , vol.16, no.2, pp.110-113, 2010 (Scopus)
2010
2010315. Rare Neurological Syndromes Associated with Systemic Lupus Erythematosus
Durmus H., Tuzun E., Alpay N., Icoz S., Kurtuncu M., Demir G. A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.47, no.1, pp.81-82, 2010 (SCI-Expanded)
2010
2010316. Paraneoplastic syndromes presenting with neurological involvement
Tüzün E.
Klinik Gelişim , vol.23, no.1, pp.71-77, 2010 (Peer-Reviewed Journal)
2010
2010317. Impact of Earthquake on Multiple Sclerosis Attacks
Tuzun E., Polat A., Akman-Demir G., Kurtuncu M., Mutlu M., Aksay B., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, no.4, pp.324-327, 2010 (SCI-Expanded)
2010
2010318. Sensorimotor neuropathy associated with endometrioid endometrial carcinoma
Durmus H., Tuzun E., Icoz S., Akman-Demir G., Parman Y.
European Journal of Obstetrics and Gynecology and Reproductive Biology
, vol.150, no.2, pp.216-217, 2010 (SCI-Expanded, Scopus)
2010
2010319. Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients
Icoz S., Tuzun E., Kurtuncu M., Durmus H., Mutlu M., Eraksoy M., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.1, pp.71-75, 2010 (SCI-Expanded, Scopus)
2009
2009320. Brainstem encephalitis following influenza vaccination: Favorable response to steroid treatment
TURKOGLU R., Tuzun E.
VACCINE
, vol.27, no.52, pp.7253-7256, 2009 (SCI-Expanded)
2009
2009321. Primary cerebral lymphoma with a 5-year remission to single-agent corticosteroids
Kurtuncu M., Tuzun E., Durmus H., Mutlu M., Akman-Demir G., Eraksoy M.
Leukemia and Lymphoma
, vol.50, no.9, pp.1552-1553, 2009 (SCI-Expanded, Scopus)
2009
2009322. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma
Tuezuen E., Zhou L., Baehring J. M., Bannykh S., Rosenfeld M. R., Dalmau J.
ACTA NEUROPATHOLOGICA
, vol.118, no.6, pp.737-743, 2009 (SCI-Expanded)
2009
2009323. Antinuclear antibodies in juvenile myoclonic epilepsy
Altindag E., Icoz S., Tuzun E., Durmus H., Uludokumaci A., Demir G. A., et al.
Journal of Neurological Sciences
, vol.26, no.1, pp.43-48, 2009 (Scopus, TRDizin)
2009
2009324. Pregnancy-Induced Atypic Demyelinating Inflammatory Disease
Durmus H., Tuzun E., Kurtuncu M., Mutlu M., Demir G. A., Eraksoy M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, no.2, pp.80-83, 2009 (SCI-Expanded)
2009
2009325. Anti-Yo-associated cerebellar syndrome presenting with a brain mass
Tuzun E., BEKTAS H. M., Icoz S., Kurtuncu M., SAIP P., Akman-Demir G.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
, no.2, pp.183-184, 2009 (SCI-Expanded)
2009
2009326. Paraneoplastic neurological syndromes
Tüzün E.
Türkiye Klinikleri Journal of Medical Research , vol.2, no.4, pp.67-74, 2009 (Peer-Reviewed Journal)
2009
2009327. Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis
LI J., QI H., Tuzun E., ALLMAN W., Yilmaz V., SAINI S. S., et al.
Journal of Neuroimmunology
, vol.208, pp.40-45, 2009 (SCI-Expanded)
2008
2008328. Multiple sclerosis: Could it be an epigenetic disease?
Kurtuncu M., Tuzun E.
MEDICAL HYPOTHESES
, vol.71, no.6, pp.945-947, 2008 (SCI-Expanded)
2008
2008329. Targeting classical complement pathway to treat complement mediated autoimmune diseases
TÜZÜN E., LI J., SAINI S. S., YANG H., CHRISTADOSS P.
Advances in Experimental Medicine and Biology
, vol.632, pp.265-272, 2008 (SCI-Expanded)
2008
2008330. Interleukin-6 in neuro-Behcet's disease: Association with disease subsets and long-term outcome
Akman-Demir G., Tuezuen E., Icoez S., Yesilot N., Yentuer S. P., Kuertuencue M., et al.
CYTOKINE
, no.3, pp.373-376, 2008 (SCI-Expanded)
2008
2008331. Anti-neuronal antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis
Kurtuncu M., Tuzun E., KAYA D., Icoz S., Baslo M. B., Ertas M., et al.
JOURNAL OF HEADACHE AND PAIN
, vol.9, no.5, pp.333-335, 2008 (SCI-Expanded)
2008
2008332. C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis
QI H., Tüzün E., ALLMAN W., SAINI S. S., PENABAD Z. R., PIERANGELI S., et al.
Journal of Neuroimmunology
, vol.196, pp.101-106, 2008 (SCI-Expanded)
2008
2008333. Inhibitory IgG receptor Fc gamma RIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis
LI J., Tuzun E., WU X. R., BIN QI H., ALLMAN W., SAINI S. S., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.194, pp.44-53, 2008 (SCI-Expanded)
2008
2008334. Anti-neuronal antibodies in small cell lung cancer patients without paraneoplastic disorders
İçöz S., Tüzün E., Oflazer P., Akman Demir G.
NOROPSIKIYATRI ARSIVI , vol.45, no.1, pp.6-8, 2008 (Peer-Reviewed Journal)
2008
2008335. Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesis
CHRISTADOSS P., Tuzun E., LI J., SAINI S. S., YANG H.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE
, vol.1132, pp.210-219, 2008 (SCI-Expanded)
2007
2007336. A new mouse model of autoimmune ocular myasthenia gravis
Yang H., Wu B., Tuezuen E., Saini S. S., Li J., Allman W., et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
, vol.48, no.11, pp.5101-5111, 2007 (SCI-Expanded)
2007
2007337. Limbic encephalitis and variants: Classification, diagnosis and treatment
Tuzun E., DALMAU J.
NEUROLOGIST
, vol.13, no.5, pp.261-271, 2007 (SCI-Expanded)
2007
2007338. A patient with encephalitis associated with NMDA receptor antibodies
SANSING L. H., Tuzun E., KO M. W., BACCON J., LYNCH D. R., DALMAU J.
NATURE CLINICAL PRACTICE NEUROLOGY
, vol.3, no.5, pp.291-296, 2007 (SCI-Expanded)
2007
2007339. Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis
Tuzun E., ROSSI J. E., KARNER S. F., CENTURION A. F., DALMAU J.
JOURNAL OF NEUROIMMUNOLOGY
, vol.186, pp.177-180, 2007 (SCI-Expanded)
2007
2007340. Limbic encephalitis associated with antibodies to cell membrane antigens
Tüzün E.
NOROPSIKIYATRI ARSIVI , vol.44, no.3, pp.101-107, 2007 (Peer-Reviewed Journal)
2007
2007341. Pros and cons of treating murine myasthenia gravis with anti-C1q antibody
Tuzun E., LI J., SAINI S. S., YANG H., CHRISTADOSS P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.182, pp.167-176, 2007 (SCI-Expanded)
2007
2007342. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis
YAPICI Z., Tuezuen E., ALTUNAYOGLU V., ERDOGAN A., ERAKSOY M.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.117, no.11, pp.1505-1512, 2007 (SCI-Expanded, Scopus)
2007
2007343. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma
Dalmau J., Tuzun E., Wu H., Masjuan J., Rossı J. E., Voloschın A., et al.
ANNALS OF NEUROLOGY
, vol.61, pp.25-36, 2007 (SCI-Expanded)
2006
2006344. Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis
Tuzun E., SAINI S. S., MORGAN B. P., CHRISTADOSS P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.181, pp.29-33, 2006 (SCI-Expanded)
2006
2006345. Immunization of mice with T cell-dependent antigens promotes IL-6 and TNF-alpha production in muscle cells
Tuzun E., LI J., WANASEN N., SOONG L., CHRISTADOSS P.
CYTOKINE
, vol.35, pp.100-106, 2006 (SCI-Expanded)
2006
2006346. Autoimmune thyroid encephalopathy presenting with epilepsia partialis continua
AYDIN-OEZEMIR Z., Tuezuen E., BAYKAN B., Akman-Demir G., OEZBEY N., GUERSES C., et al.
CLINICAL EEG AND NEUROSCIENCE
, vol.37, no.3, pp.204-209, 2006 (SCI-Expanded)
2006
2006347. Genetic evidence for the involvement of Fc gamma receptor III in experimental autoimmune myasthenia gravis pathogenesis
Tuzun E., Saini S. S., Yang H., Alagappan D., Higgs S., Christadoss P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.174, pp.157-167, 2006 (SCI-Expanded)
2006
2006348. Unraveling myasthenia gravis immunopathogenesis using animal models
Tüzün E., Christadoss P.
DRUG DISCOVERY TODAY: DISEASE MODELS , vol.3, no.1, pp.15-20, 2006 (Scopus)
2006
2006349. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis
Tuzun E., SAINI S., GHOSH S., ROWIN J., MERIGGIOLI M., CHRISTADOSS P.
NEUROMUSCULAR DISORDERS
, vol.16, no.2, pp.137-143, 2006 (SCI-Expanded)
2006
2006350. Neuronal acetylcholine receptor alpha 9-subunit: A possible central nervous system autoantigen
Tuzun E.
MEDICAL HYPOTHESES
, vol.67, no.3, pp.561-565, 2006 (SCI-Expanded)
2005
2005351. The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit
SAINI S., Tuzun E., CHRISTADOSS P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.169, pp.177-179, 2005 (SCI-Expanded)
2005
2005352. IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1
Yang H., Tuzun E., Alagappan D., Yu X., Scott B., Ischenko A., et al.
JOURNAL OF IMMUNOLOGY
, vol.175, no.3, pp.2018-2025, 2005 (SCI-Expanded)
2005
2005353. Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment
Tuzun E., MERIGGIOLI M., ROWIN J., YANG H., CHRISTADOSS P.
JOURNAL OF AUTOIMMUNITY
, vol.24, no.3, pp.261-268, 2005 (SCI-Expanded)
2004
2004354. Etanercept treatment in corticosteroid-dependent myasthenia gravis
ROWIN J., MERIGGIOLI M., Tuzun E., LEURGANS S., CHRISTADOSS P.
NEUROLOGY
, vol.63, no.12, pp.2390-2392, 2004 (SCI-Expanded)
2004
2004355. ICOS is essential for the development of experimental autoimmune myasthenia gravis
SCOTT B., YANG H., Tuzun E., DONG C., FLAVELL R., CHRISTADOSS P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.153, pp.16-25, 2004 (SCI-Expanded)
2004
2004356. Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS/J mice
Tuzun E., SCOTT B., YANG H., WU B., GOLUSZKO E., GUIGNEAUX M., et al.
JOURNAL OF IMMUNOLOGY
, vol.172, no.9, pp.5743-5752, 2004 (SCI-Expanded)
2003
2003357. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis
Tuzun E., SCOTT B., GOLUSZKO E., HIGGS S., CHRISTADOSS P.
JOURNAL OF IMMUNOLOGY
, vol.171, no.7, pp.3847-3854, 2003 (SCI-Expanded)
2003
2003358. B7-1 costimulatory molecule is critical-for the development of experimental autoimmune myasthenia gravis
POUSSIN M., Tuzun E., GOLUSZKO E., SCOTT B., YANG H., FRANCO J., et al.
JOURNAL OF IMMUNOLOGY
, vol.170, no.8, pp.4389-4396, 2003 (SCI-Expanded)
2003
2003359. Autoimmune disorders of neuronal potassium channels
Newsom-Davis J., BUCKLEY C., CLOVER L., Hart I., MADDISON P., Tuzum E., et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS
, vol.998, pp.202-210, 2003 (SCI-Expanded)
2002
2002360. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production
DENG C., GOLUSZKO E., Tuzun E., YANG H., CHRISTADOSS P.
JOURNAL OF IMMUNOLOGY
, vol.169, no.2, pp.1077-1083, 2002 (SCI-Expanded)
2001
2001361. Paroxysmal attacks in multiple sclerosis
Tuzun E., AKMAN-DEMIR G., ERAKSOY M.
MULTIPLE SCLEROSIS
, vol.7, no.6, pp.402-404, 2001 (SCI-Expanded)
2001
2001362. Potassium channel antibodies in two patients with reversible limbic encephalitis
BUCKLEY C., OGER J., CLOVER L., Tuzun E., CARPENTER K., JACKSON M., et al.
ANNALS OF NEUROLOGY
, vol.50, no.1, pp.73-78, 2001 (SCI-Expanded)
2001
2001363. F wave parameters and F tacheodispersion in mild diabetic neuropathy.
TÜZÜN E., Oge A. E., ERTAŞ M., BOYACÍYAN A., DINÇÇAĞ N., YAZÍCÍ J.
Electromyography and clinical neurophysiology
, vol.41, no.5, pp.273-9, 2001 (Peer-Reviewed Journal)
2001
2001364. Clinical and laboratory features of cases with isolated acute behavioral changes
Tüzün E., Kıyat Atamer A., Özdemir Ö., Gürvit İ. H.
NOROPSIKIYATRI ARSIVI , vol.38, no.4, pp.223-227, 2001 (Peer-Reviewed Journal)
2001
2001365. Lafora body-like inclusions in a case of progressive myoclonic ataxia associated with coeliac disease
Tuzun E., GURSES C., BAYKAN B., BUYUKBABANI N., OZTURK A., GOKYIGIT A. Z.
EUROPEAN NEUROLOGY
, vol.46, no.3, pp.157-158, 2001 (SCI-Expanded)
2001
2001366. Morvan's syndrome: New insights into the mechanisms of thalamic insomnia
Tüzün E.
JOURNAL OF NEUROLOGICAL SCIENCES
, vol.18, no.1, pp.14801, 2001 (Peer-Reviewed Journal)
2000
2000368. Longterm follow-up of electroencephalographic and clinical findings of a case with Gaucher's disease type 3a
Tuzun E., Baykan B., GURSES C., GOKYIGIT A. Z.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
, vol.9, no.7, pp.469-472, 2000 (SCI-Expanded)
2000
2000369. Possible role of gangliosides in salivary gland complications of diabetes
Tuzun E., HATEMI A., MEMISOGLU K.
MEDICAL HYPOTHESES
, vol.54, no.6, pp.910-912, 2000 (SCI-Expanded)
2000
2000370. Amyotophic lateral sclerosis and frontal lobe dementia
Tüzün E., Hanağası H. A., Kaptanoğlu G., Gürvit İ. H.
TURK NOROLOJI DERGISI , vol.1, no.1, pp.67-74, 2000 (Peer-Reviewed Journal)
1999
1999371. A case of intracranial granulocytic sarcoma (chloroma)
Tüzün E., Krespi Y., Tuncay R., Çoban O., Bahar S.
NOROPSIKIYATRI ARSIVI , vol.36, no.1, pp.23-26, 1999 (Peer-Reviewed Journal)
1998
1998372. Intracavernosal endothelin levels of impotent men before and after papaverine induced penile erection.
Kadioǧlu A., Memişoǧlu K., Sazoya O., Tüzün E.
Archivos espanoles de urologia
, vol.51, no.7, pp.739-40, 1998 (Scopus)
1998
1998373. Anterior choroidal artery territory infarction: A case report and review
Tuzun E.
ARCHIVES OF MEDICAL RESEARCH
, vol.29, no.1, pp.83-87, 1998 (SCI-Expanded)
1997
1997374. Serum sialic acid levels are not altered in streptozotocin (STZ) induced diabetic rats
Tuzun E., HATEMI A., MEMISOGLU K., SAZOVA O.
Turkish Journal of Medical Sciences
, vol.27, no.6, pp.531-533, 1997 (SCI-Expanded)
1997
1997375. Impotence due to reduced central nitric oxide synthase activity in hypogonadal males
Tuzun E.
ARCHIVES OF MEDICAL RESEARCH
, vol.28, no.3, pp.431, 1997 (SCI-Expanded)
1994
1994376. Treatment of congenital SST deformity with a new technique
Babacan S., Kadıoğlu A., Tüzün E., Doğruer K., Erdoğru T., Memişoğlu K., et al.
TURKISH JOURNAL OF UROLOGY , vol.20, no.4, pp.451-455, 1994 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. Memory Impairment and Synaptic Alterations Induced by Anti-GABABR Antibodies in a Rat Model of Autoimmune Encephalitis.
Sancar N., Yüceer Korkmaz H., Yalcın Celıkel B., Soylu S., Yıldız N., Ulusoy C. A., et al.
International Society of Neuroimmunology Congress 2025 (ISNI 2025), Chiba, Japan, 5 - 08 October 2025, pp.1, (Summary Text)
2025
20252. Patient-derived polyclonal NMDAR antibodies cause epileptic seizures and sleep–wake disturbances in a passive transfer rat model
Çarçak Yılmaz N., Yüceer Korkmaz H., Yalcın B., Yıldız N., Ulusoy C. A., Şanlı E., et al.
36th International Epilepsy Congress, Lisbon, Portugal, 30 August - 03 September 2025, pp.1, (Summary Text)
2025
20253. Characterizing Immune Cell Dynamics in Anti-NMDAR Encephalitis via Single-Cell Transcriptomics
Şanlı E., Karaaslan Z., Yılmaz V., Uygunoğlu U., Uğur İşeri S. A., Tüzün E.
IMMUNOLOGY2025, Hawaii, United States Of America, 3 - 07 May 2025, (Unpublished)
2025
20254. Effects of IL-4Rα shRNA Lentiviral Particles Treatment in Experimental Autoimmune MuSK Myasthenia Gravis Model
Koral G., Mountadir I., Lazaridis K., Tüzün E., Yılmaz V.
15th International Conference on Myasthenia and Related Disorders, The Hague, Netherlands, 13 - 15 May 2025, (Unpublished)
2025
20255. DENEYSEL OTOİMMÜN MUSK MİYASTENİA GRAVİS MODELİNDE IL-4Rα SHRNA TEDAVİSİNİN ETKİSİ
ULUSOY C. A., Koral G., Sancar N., Mountadir I. F., Lazaridis K., TÜZÜN E., et al.
12.Nöroimmünoloji Okulu, 8 - 11 May 2025, (Summary Text)
2024
20246. Anti-CD20 Tedavisi Altındaki MS Hastalarının Hücre Gruplarının Dağılımı Ve Serum Sitokin Seviyeleri.
Akbayır E., Ulusoy C. A., Koral G., Erol R., Demir A. S., Kızılay T., et al.
13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Turkey, 13 - 18 May 2024, (Unpublished)
2024
20247. Okrelizumab Tedavisi Alan RRMS Hastalarında BOS Nörofilaman Hafif Zincir Ve Nörogranin Seviyelerindeki Değişiklik Tedaviye Yanıtı Ve Hastalık Aktivitesini Öngördürebilir Mi?
Kızılay T., Akbayır E., Erol Yıldız R., Ersöz A. S., Özkan Yaşargün D., Yılmaz V., et al.
Klinik Nöroimmunoloji Sempozyumu, Antalya, Turkey, 13 - 18 May 2024, pp.1-5, (Summary Text)
2024
20248. İVİG Tedavisinin Uykuda Elektriksel Status Epileptikus Hastalarındaki İmmün Cevap ile İlişkisi.
Koral G., Soylu S., Topaloğlu P., Emekli A. S., Karaaslan Z., Yüceer Korkmaz H., et al.
13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Turkey, 13 - 18 May 2024, (Unpublished)
2024
20249. Aterosklerotik Karotis Hastalığında Doğal İmmün Sistemin Rolü.
Koral G., Günbek S., Yalçın B., Yusifli S., Sezgin M., Yeşilot N., et al.
13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Turkey, 13 - 18 May 2024, (Unpublished)
2024
202410. Agresif Seyirli Multiple Skleroz Hastalarında Biyobelirteçlerin Klinik Ve Radyolojik Bulgularla İlişkisi.
Erol Yıldız R., Akbayır E., Ersöz A. S., Yılmaz V., Tüzün E., Türkoğlu R.
13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Turkey, 13 - 18 May 2024, (Unpublished)
2024
202411. Otoimmün Ensefalitlerde Antikor Varlığının Hücre Temelli Yöntem ile Doğrulanması
Şanlı E., Karaaslan Z., Yılmaz V., Özkara Ç., Terzi M., Baykal B., et al.
13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Turkey, 13 - 18 May 2024, (Unpublished)
2024
202412. Neuronal-glial mechanisms and electrophysiological insights into spatial memory impairments in the anti-NMDAR encephalitis mouse model.
Yüceer Korkmaz H., Yılmaz V., Tüzün E., Hussaını A.
Society for Neuroscience (SfN), Illinois, United States Of America, 5 - 09 October 2024, pp.1, (Summary Text)
2024
202413. Baseline cerebrospinal fluid levels of BDNF predict disease activity in MS: A Prospective Study
Yildiz R. E., Qkbayir E., Ersoz A. S., YILMAZ V., TÜZÜN E., Turkoglu R.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, vol.30, pp.592-593, (Summary Text)
2024
202414. Aquaporin-1 antibodies in autoimmune inflammatory demyelinating disorders with predominant optic nerve & spinal cord involvement
TÜZÜN E., Kaptov E., YILMAZ V., Pechlivanidou M., KÜRTÜNCÜ M., GÜNDÜZ T., et al.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, vol.30, pp.885, (Summary Text)
2024
202415. Distribution of immune cell groups and cytokine levels in MS patients under ocrelizumab treatment
Turkoglu R., Akbayir E., ULUSOY C. A., Koral G., YILMAZ V., TÜZÜN E.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, vol.30, pp.1013-1014, (Summary Text)
2023
202316. Nadir Nörogenetik Bir Hastalik Modeli Olarak Epileptik Ensefelopatilerde Trio Ekzom Dizileme Analizleri
Karaaslan Z., Salman B., Ovamigyan S. A., Kılıç M., Çırak S., Uğur İşeri S. A., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, pp.25, (Summary Text)
2023
202317. Uykuda elektriksel status epileptikus hastalarında immün tedavilerin nöropsikiyatrik ve dil bozuklukları üzerine etkisi
Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., Topaloğlu P., Çırak S., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, pp.19, (Summary Text)
2023
202318. Otoimmün Ensefalit Hastalarinda Uyku Şikayetleri, Polisomnografi Bulgulari Ve Hastalik Seyri İle İlişkisi
Tüzün E., Yılmaz V., Karadeniz D., Akyıldız U. O., İlhan Algın D., Sarıtaş A. Ş., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, pp.109, (Summary Text)
2023
202319. Otoimmün Demiyelizan Hastalıkların Ayırıcı Tanısında CCL4L2’nin B Hücre Temelli Biyobelirteç Olarak Değeri
Koral G., Akpunar F., Şanlı E., Karaaslan Z., Yüceer H., Özkan E., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, pp.89, (Summary Text)
2023
202320. Nedeni Belirlenemeyen Nöbeti Olan Çocuklarda Kelch Benzeri Protein 11 (Klhl11) Antikoru
Günbek S., Tzartos J., Pechlivanidou M., Despoina B., Ninou E., Yüceer Korkmaz H., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, (Unpublished)
2023
202321. Akut İskemik İnmeli Hastaların İnme Sonrası Serumlarında Serebellar Antikorlar
Atmaca M. M., Erdağ E., Demir S., Yüceer Korkmaz H., Çolak Atmaca M., Küçükali C. I., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, (Unpublished)
2023
202322. Genetik Absans Epilepsili Sıçanlarda İntraserebroventriküler LGI1 Antikor Uygulamasının Spontan Diken-Yavaş-Dalga Deşarjlar Üzerine Etkisi
Çarçak Yilmaz N., Akat Ş., Yalçin B., Yüceer Korkmaz H., Ulusoy C. A., Küçükali C. I., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, (Unpublished)
2023
202323. Unraveling Neuronal and Glial Mechanisms in Anti-NMDAR Encephalitis: Perspectives from Mouse, Rat, and Zebrafish Models
Yüceer Korkmaz H., Bhattarai P., Yilmaz V., Kizil Ç., Tüzün E., Hussaini S. A.
13th Annual Taub Institute Research Retreat, New York, United States Of America, 08 November 2023, (Unpublished)
2023
202324. The Effect of Multiple Sclerosis Sera on Pericyte Survival
Akbayir E., Turkoglu R., Ulusoy C. A., Yılmaz V., Kürtüncü M., Küçükali C. İ., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, Italy, 11 - 13 October 2023, pp.825-826, (Summary Text)
2023
202325. Possible Diagnostic Biomarkers in The Differential Diagnosis of Autoimmune Demyelinating Central Nervous System Diseases: Sorcin and CLIC1
Karaaslan Z., Şengül Yediel B., Şanlı E., Yüceer H., Dursun E., Gezen Ak D., et al.
9th Joint ECTRIMS-ACTRIMS Meeting, Milan, Italy, 11 - 13 October 2023, vol.29, no.3, pp.574-575, (Summary Text)
2023
202326. Patients with epileptic seizures in the intensive care unit is distinguished from other diseases by IL-1beta and IL-8 levels but not markers of glial activation.
Şanlı E., Altundağ E., İlgen Uslu F., Karaaslan Z., Akbayır E., Koral G., et al.
XVII Workshop on Neurobiology of Epilepsy – WONOEP 2023, Dublin, Ireland, 28 - 31 August 2023, pp.24, (Summary Text)
2022
202227. WEST Sendromunda Periferik Kan Hücrelerinin Dağılımının Tedaviye Yanıt ile İlişkisi
Yılmaz V., Soylu S., Cherkazzade M., Akbayır E., Yüceer H., Koral G., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, pp.121, (Summary Text)
2022
202228. Epilepsia Parsiyalis Kontinua Olgularında Kompleman Aracılı Nöroinflamasyonun Olası Rolü
Altındağ E., Şanlı E., Ilgen Uslu F., Yılmaz V., Ekizoğlu Turgut E., Küçükali C. İ., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, pp.128, (Summary Text)
2022
202229. Epileptik Ensefalopati: Glial Aktivite Faktörleri Biyobelirteç Olarak Kullanılabilir Mi?
Charkazzade M., Soylu S., Tüzün E., Yılmaz V., Sezgin M., Yapıcı Z., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, pp.196, (Summary Text)
2022
202230. MS Hasta Serumlarında Bulunan Faktörler In Vitroda Perisit Sağkalımını Etkiler Mi?
Akbayır E., Ulusoy C. A., Yılmaz V., Kürtüncü M., Küçükali C. İ., Tüzün E.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, pp.212, (Summary Text)
2022
202231. Multipl Skleroz Hastalarında Beyin Omurilik Sıvısı Nörofilament Hafif Zincir Seviyesinin Prognostik Değeri
Demirel A., Şahin E., Gündüz T., Yılmaz V., Tüzün E., Öztürk Erden S., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, pp.63, (Summary Text)
2022
202232. Silencing KCNS3 and FCRLB Genes in Experimental Model of MuSK Myasthenia Gravis: Two Novel Molecules in MG Pathogenesis
Koral G., Ulusoy C. A., Şahin H., Soylu S., Akbayır E., Tüzün E., et al.
5th International Molecular Immunology and Immunogenetics Congress (MIMIC V), İzmir, Turkey, 20 - 22 October 2022, pp.14, (Summary Text)
2022
202233. Evaluation of SARS-CoV-2 Specific Antibody Responses in Asymptomatic and Symptomatic Cases.
Öktelik F. B., Yılmaz V., Gelmez M. Y., Akdeniz N., Köse M., Tüzün E., et al.
5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 8 - 12 November 2022, pp.54, (Summary Text)
2022
202234. West sendromunda periferik kan hücre dağılımı ve inflamazom aktivitesinin immünopatogeneze ve tedaviye yanıta etkisi
SOYLU S., CHERKEZZADE M., AKBAYIR E., YÜCEER H., KORAL G., ŞANLI E., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, (Summary Text)
2022
202235. Otoimmün ensefalit sıçan modelinde intraserebroventriküler NMDAR ve LGI1 antikoru uygulaması sonrasında artan nöbet duyarlılığı ve bozulan bellek işlevi
YÜCEER H., AKAT PİŞKİN Ş., ULUSOY C. A., KARAASLAN Z., SOYLU S., ERDAĞ E., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, (Summary Text)
2022
202236. Otoimmün demiyelinizan santral sinir sistemi hastalıkları ayırıcı tanısında olası biyobelirteçler: Sorcin, CLIC1 ve Src substrate cortactin
Karaaslan Z., Şengül Yediel B., Şanlı E., Yüceer H., Dursun E., Gezen Ak D., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 18 - 24 November 2022, pp.200, (Summary Text)
2022
202237. Evaluation of SARS-CoV-2 Specific Antibody Responses in Asymptomatic and Symptomatic Cases
Öktelik F. B., Yılmaz V., Gelmez M. Y., Akdeniz N., Köse M., Tüzün E., et al.
5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 20 - 22 October 2022, pp.251, (Summary Text)
2022
202238. MuSK Myasthenia Gravis fare modelinde KCNS3 ve FCRLB genlerinin susturulması
Koral G., Ulusoy C. A., Soylu S., Şanlı E., Tüzün E., Yılmaz V.
20. Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 19 - 23 October 2022, pp.98, (Summary Text)
2022
202239. Silencing KCNS3 And FCRLB Genes İn The Experimental Model Of Musk Myasthenia Gravis: Two Novel Molecules in MG Pathogenesis
Koral G., ULUSOY C. A., Şahin H., Soylu S., Akbayır E., TÜZÜN E., et al.
5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 20 - 22 October 2022, (Full Text)
2022
202240. Sıçanlarda LGI1 antikorunun intraserebroventriküler uygulanması ile artan nöbet şiddeti ve bozulan bellek işlevi
AKAT PİŞKİN Ş., YÜCEER H., ULUSOY C. A., SOYLU S., KARAASLAN Z., ERDAĞ E., et al.
20. Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 19 - 23 October 2022, (Summary Text)
2022
202241. West sendromunda periferik kan hücrelerinin dağılımının tedaviye yanıt ile ilişkisi
SOYLU S., CHERKEZZADE M., AKBAYIR E., YÜCEER H., KORAL G., ŞANLI E., et al.
20. Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 19 - 23 October 2022, (Summary Text)
2022
202242. B cell gene expression profile in different demyelinating diseases
Karaaslan Z., Şanlı E., Yüceer H., Timirci Kahraman Ö., Gündüz T., Kürtüncü M., et al.
International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Turkey, 20 - 22 October 2022, (Summary Text)
2022
202243. Intracerebroventricular injection of LGI1 antibody increase seizure susceptibility and disrupts cognitive performance in autoimmune encephalitis rat model
Yüceer H., Akat Pişkin Ş., Ulusoy C. A., Soylu S., Karaaslan Z., Erdağ E., et al.
International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Turkey, 20 - 22 October 2022, (Summary Text)
2022
202244. Evaluation of SARS-CoV-2 Specific Antibody Responses in Asymptomatic and Symptomatic Cases.
Öktelik F. B., Yılmaz V., Gelmez M. Y., Akdeniz N., Köse M., Tüzün E., et al.
5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 20 - 22 October 2022, pp.1, (Summary Text)
2022
202245. Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios
Tuzun E., Turkoglu R., Oezguen N., Yilmaz V., Akbayir E., Horvath T. D., et al.
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, vol.28, pp.778, (Summary Text)
2022
202246. Increased seizure susceptibility and disturbed cognitive performence after intracerebroventricular injections of NMDAR antibody in passive transfer rat model of autoimmune encephalitis
AKAT PİŞKİN Ş., YÜCEER H., ULUSOY C. A., KÜÇÜKALİ C. İ., ONAT F., TÜZÜN E., et al.
14th European Epilepsy Congress, Geneva, Switzerland, 9 - 13 July 2022, (Summary Text)
2022
202247. Increased seizure susceptibility and disturbed cognitive performance after intracerebroventricular injections of NMDAR antibody in passive transfer rat model of autoimmune encephalitis
Akat Pişkin Ş., Yüceer H., Küçükali C. I., Onat F., Tüzün E., Çarçak Yılmaz N.
14th European Epilepsy Congress, Geneve, Switzerland, 9 - 13 July 2022, (Unpublished)
2022
202248. Diagnostic and Theraputic Autoantibody Discovery Studies for Brain Tumors
Topçu O., Timirci Kahraman Ö., Sabancı P. A., Aras Y., Yetimler B., Mohr T., et al.
5th Annual Meeting New Diagnostic and Therapeautic Tools Against Multidrug Resistance Tumors, Coimbra, Portugal, 29 June - 01 July 2022, pp.50-51, (Summary Text)
2022
202249. Increased Seizure Susceptibility and Impaired Cognitive Performance after Intracerebroventricular Nmdar Antibody Administration in a Passive Transfer Rat Autoimmune Encephalitis Model
Yüceer H., Akat Pişkin Ş., Ulusoy C. A., Karaaslan Z., Çırak S., Çarçak Yılmaz N., et al.
13. Ulusal Epilepsi Kongresi, Muğla, Turkey, 26 - 29 May 2022, (Unpublished)
2022
202250. NSC-87877, Inhibıtor Of Src Homology 2 Domain-Containing Phosphotyrosine Phosphatase 2, Ameliorates Experimental Autoimmune Myasthenia Gravis Induced By Musk Immunizatıon
YILMAZ V., Koral G., Cao M., Liu W., Maxwell S., Webster R., et al.
14th MGFA International Conference On Myasthenia And Related Disorders, United States Of America, 10 - 12 May 2022, (Full Text)
2022
202251. NSC-87877, Inhibıtor Of Src Homology 2 Domain-Containing Phosphotyrosine Phosphatase 2, Ameliorates Experimental Autoimmune Myasthenia Gravis Induced By Musk Immunization
Yılmaz V., Koral G., Cao ., Liu W. W., Maxwell S., Webster R., et al.
14th MGFA International Conference On Myasthenia And Related Disorders, Florida, United States Of America, 10 - 12 May 2022, vol.65, pp.45, (Summary Text)
2021
202152.
Şanlı E., Yılmaz V., Şirin Inan N. G., Koral G., Küçükali C. I., Bebek N., et al.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Unpublished)
2021
202153. Immunothrombotic Markers in COVID-19 Pneumonia Concurrent Ischemic Stroke
Duran Bayar M., Şişman A. B., Çırak S., Erdağ E., Yılmaz V., Tüzün E., et al.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Unpublished)
2021
202154. Clinical and Electrophysiological Characteristics of Guillain-Barré Syndrome Before and During the Pandemic: Multicenter Istanbul Study
Taşdemir V., Şirin İnan N. G., Çakar A., Çulha A., Soysal A., Elmalı Yazıcı A. D., et al.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Unpublished)
2021
202155. SWAP-70 ve FCRL2 moleküllerinin multipl skleroz fizyopatolojisindeki rolü ve biyobelirteç olarak değeri
Akbayır E., Şekerdağ E., Erdağ E., Şanlı E., Ulusoy C. A., Koral G., et al.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Unpublished)
2021
202156. Investigation of Immune Mechanisms Associated with Narcolepsy by Microarray Method
Yüceer H., Timirci Kahraman Ö., Benbir Şenel G., Karadeniz D., Tüzün E., Küçükali C. İ.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, pp.77, (Full Text)
2021
202157. Effects of Intraventricular Anti-NMDAR Antibody Positive Autoimmune Encephalitis Patient Serum IgG Administration on Epileptic Seizure and Behavior in Wistar Rats.
Yüceer H., Akat Ş., Ulusoy C. A., Karaaslan Z., Çırak S., Çarçak Yılmaz N., et al.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, pp.43, (Full Text)
2021
202158. Periferik Kan İmmünfenotiplemesi OSMS'yi NMOSH'den Ayırabilir mi?
KARAASLAN Z., ŞANLI E., YÜCEER H., ULUSOY C. A., KÜÇÜKALİ C. İ., TİMİRCİ KAHRAMAN Ö., et al.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)
2021
202159. The role of SWAP-70 and FCRL2 in the pathophysiology of multiple sclerosis and their value as a biomarker.
Şanlı E., Şekerdağ-Yılmaz E., Erdağ Turgeon E., Akbayır E., Ulusoy C. A., Koral G., et al.
15th International Society of Neuroimmunology (ISNI) Congress, Antibes, France, 8 - 12 November 2021, pp.45, (Summary Text)
2021
202160. The role of SWAP-70 and FCRL2 in the pathophysiology of multiple sclerosis and their value as a biomarker
ŞANLI E., Şekerdağ Yılmaz E., ERDAĞ E., Akbayır E., ULUSOY C. A., Koral G., et al.
15th International Society of Neuroimmunology (ISNI) Congress, France (Virtual)., 8 - 12 November 2021, (Full Text)
2021
202161. Serum IgG of NMDAR Antibody Positive Encephalitis Patients Delays Absence Seizure Onset and Prolongs Seizure Duration in Rats
Yüceer H., Akat Ş., Ulusoy C. A., Karaaslan Z., Çırak S., Çarçak Yılmaz N., et al.
15th International Society of Neuroimmunology (ISNI) Congress, Nice, France, 8 - 12 November 2021, (Unpublished)
2021
202162. Can OSMS be differentiated from NMOSD and MS by peripheral blood immunophenotyping?
Şanlı E., Karaaslan Z., Yüceer H., Ulusoy C. A., Küçükali C. İ., Timirci Kahraman Ö., et al.
15th International Society of Neuroimmunology (ISNI) Congress, Nice, France, 8 - 12 November 2021, (Unpublished)
2021
202163. Benign multiple sclerosis patients display altered peripheral blood B cell subset ratios and B cell gene expression levels
Akbayır E., Şanlı E., Ulusoy C. A., Özdemir Ö., Benbir Şenel G., Arsoy E., et al.
European Congress of Immunology, 1 - 04 September 2021, (Unpublished)
2020
202064. Parkinson's Disease: Do SUMO Gene Variants Play A Role in Etiopathogenesis?
Yüceer H., Küçükali C. İ., Tüzün E., Bilgiç B., Ergen H. A., Hanağası H. A.
31. Ulusal Biyokimya Kongresi, İstanbul, Turkey, 18 - 20 December 2020, pp.80, (Summary Text)
2019
201965. Hippokampal Sklerozla İlişkili Mezyal Temporal Lob Epilepsisi ve Nedeni Bilinmeyen Fokal Epilepsilerde İnflamazom ve İnflamatuvar Faktörlerin Rolü
Ulusoy C. A., Vanlı Yavuz E. N., Şanlı E., Timirci Kahraman Ö., Yılmaz V., Bebek N., et al.
55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 16 - 21 November 2019, (Unpublished)
2019
201966. Glioblastoma Multiforme Erken Tanı ve Tedavisine İmkan Sağlayabilecek Otoantikorların Tanımlanması
Timirci Kahraman Ö., Topçu O., Sabancı P. A., Aras Y., Bilgiç M. B., Ünverengil G., et al.
55. Ulusal Nöroloji Kongresi , Antalya, Turkey, 15 - 21 November 2019, pp.1, (Summary Text)
2019
201967. Küme Başağrısı Patofizyolojisinde İnflamasyonun Olası Rolünün İnflamazom Kompleksiyle Değerlendirilmesi
Küçükali C. İ., Ulusoy C. A., Ekizoğlu Turgut E., Kocasoy Orhan E., Tüzün E., Baykal B.
55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 16 - 21 November 2019, (Unpublished)
2019
201968. NARKOLEPSİYE ÖZGÜ OTOANTİKORLARIN İMMÜNOPRESİPİTASYON VE KÜTLE SPEKTROFOTOMETREİLE TANIMLANMASI VE VALİDASYONU
YÜCEER H., BENBİR ŞENEL G., KARADENİZ D., TÜZÜN E., YILMAZ V.
55. Ulusal Nöroloji Kongresi, Turkey, 16 - 20 November 2019, (Full Text)
2019
201969. Glisin Reseptör Antikoru Pozitif Kriptojenik Fokal Epilepsi Hastalarının Periferik Kan Hücrelerinin İmmünfenotipik Değerlendirmesi
Şanlı E., Küçükali C. İ., Baykal B., Yılmaz V., Tüzün E.
55.Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 - 21 November 2019, pp.71, (Summary Text)
2019
201970. Narkolepsiye Özgü Otoantikorların İmmünopresipitasyon ve Kütle Spektrofotometre ile Tanımlanması ve Validasyonu
YÜCEER H., KÜÇÜKALİ C. İ., YILMAZ V., GEZEN AK D., DURSUN E., BENBİR ŞENEL G., et al.
55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 16 - 20 November 2019, (Summary Text)
2019
201971. Identification and validation of narcolepsy-spesific autoantibodies with immunoprecipitation and mass spectrophotometry
Yüceer H., Küçükali C. İ., Yılmaz V., Gezen Ak D., Dursun E., Benbir Şenel G., et al.
55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 16 - 20 November 2019, (Summary Text)
2019
201972. Hippokampal Sklerozla İlişkili Mezyal Temporal Lob Epilepsi ve Nedeni Bilinmeyen Fokal Epilepsilerde İnflamazom ve İnflamatuvar Faktörlerin Rolü
ULUSOY C. A., VANLI YAVUZ E. N., ŞANLI E., TİMİRCİ KAHRAMAN Ö., YILMAZ V., BEBEK N., et al.
55. Ulusal Nöroloji Kongresi (Uluslararası Katılımlı), Turkey, 15 - 21 November 2019, (Full Text)
2019
201973. Parkinson Hastalığı Patogenezinde Rol Alan Olası Moleküler Mekanizmalar: PI3K-Akt ve P53 Sinyal Yolakları
Karaaslan Z., Şanlı E., Timirci Kahraman Ö., Ergen H. A., Bilgiç B., Tüzün E., et al.
55.Ulusal Nöroloji Kongresi,, Antalya, Turkey, 15 - 19 November 2019, pp.78, (Summary Text)
2019
201974. Cognitive assessment and cytokine profile of multiple sclerosis patients presenting with only optic neuritis and myelitis
TÜZÜN E., ARSOY E., AKBAYIR E., ŞEN M., MERCAN Ö., GENCER M., et al.
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.849, (Summary Text)
2019
201975. Glisin Reseptör Antikoru Pozitif Kriptojenik Fokal Epilepside Periferik Kan Hücrelerinin İmmünfenotiplendirilmesi ve Antijenik Yanıtlarının Araştırılması
ŞANLI E., Akbayır E., KÜÇÜKALİ C. İ., BAYKAL B., YILMAZ V., TÜZÜN E.
VII. Uluslararası Moleküler Tıp Kongresi, İstanbul, Turkey, 5 - 07 September 2019, pp.1, (Summary Text)
2019
201976. Immunophenotyping and investigation of antigenic responses of peripheral blood cells in glycine receptor antibody positive cryptogenic focal epilepsy
Şanlı E., Küçükali C. İ., Baykal B., Yılmaz V., Tüzün E.
VII. International Congress of Molecular Medicine, İstanbul, Turkey, 5 - 07 September 2019, pp.50-53, (Full Text)
2019
201977. Identification and validation of narcolepsy-spesific autoantibodies with immunoprecipitation and mass spectrophotometry
Küçükali C. İ., Yüceer H., Yılmaz V., Gezen Ak D., Dursun E., Benbir Şenel G., et al.
VII. International Congress of Molecular Medicine, İstanbul, Turkey, 5 - 07 September 2019, (Unpublished)
2019
201978. Low prevalence of autoantibodies related to neuronal and rheumatic autoimmune disease in sera of patients with psychotic disorders
hoffmann c., Zong S., Mané-Damas M., , Stevens J. ,., Nogales-Gadea G., KÜÇÜKALİ C. İ., et al.
FENS Regional Meeting (FRM) (2019, Belgrade, Serbia), Belgrade, Serbia, 10 - 13 July 2019, pp.29, (Summary Text)
2019
201979. COGNITIVE IMPAIRMENT IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: EARLY DETECTION WITH MR SPECTROSCOPY AND ITS ASSOCIATION WITH MOG ANTIBODIES
Kilic H., Sahin S., Toprak M. F., Hatay G. H., YILMAZ K., ADROVIC YILDIZ A., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.982, (Summary Text)
2019
201980. DECREASED LEVELS OF Akt AND p-Akt1 IN PERIPHERAL CD4+CD25+CD127-/LOW REGULATOR T CELLS OF MULTIPLE SCLEROSIS PATIENTS
Öktelik F. B., YILMAZ V., Türkoğlu R., TÜZÜN E., DENİZ G., ÇINAR S.
International Molecular Immunology & Immunogenetics Congress IV ( MIMIC IV), Bursa, Turkey, 27 - 29 April 2019, vol.PA119, pp.118, (Full Text)
2019
201981. The role of pericytes in MS pathophysiology.
Küçükali C. İ., Tüzün E., Ulusoy C. A., Özdemir Y.
VII. International Congress of Molecular Medicine, İstanbul, Turkey, 5 - 07 September 2019, pp.92-15, (Summary Text)
2019
201982. Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis
Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Ulusoy C., et al.
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)
2019
201983. Microarray Analysis Indicates Altered Expression Levels of B Cell Genes in Benign Multiple Sclerosis
Turkoglu R., Akbayir E., Sen M., Yilmaz V., Kucukali C., Tuzun E.
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)
2019
201984. The Role of Pericytes in the Pathophysiology Multiple of Sclerosis
Tuzun E., Sekerdag E., Atak D., Yilmaz A., Ulusoy C., Zeybel M., et al.
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)
2019
201985. Co-existence of Multiple Sclerosis and Anti-NMDA Receptor Encephalitis: What We Can Learn From It?
Gulec B., Kurucu H., Bozbay S., Dikmen Y., Sayman H., Tuzun E., et al.
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)
2019
201986. Serum Levels of Inflammasome Complex Factors are Suppressed in Focal Epilepsy Patients
Yavuz E. N., Tuzun E., Ulusoy C., Kucukali C. I., Bebek N., Baykan B.
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)
2019
201987. Serum levels of inflammasome complex factors are suppressed in focal epilepsy patients
Küçükali C. İ., Tüzün E., Ulusoy C. A., Bebek N., Baykal B.
AAN 71st Annual Meeting, Pennsylvania, United States Of America, 4 - 10 May 2019, pp.92-15, (Summary Text)
2019
201988. Multiple Skleroz Patofizyolojisinde Perisitlerin Rolü
Küçükali C. İ., Ulusoy C. A., Yılmaz V., Özdemir Y., Tüzün E.
55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 16 - 21 November 2019, (Unpublished)
2018
201889. Antidepressant effect of ketamine in chronic unpredictable mild stress model: Involvement of nod-like protein inflammasome driven pathway
Aricioglu F., Yalcinkaya C., Ozkartal C. S., Tuzun E., Kucukali C. İ., Kandemir C., et al.
31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, Spain, 6 - 09 October 2018, vol.29, (Summary Text)
2018
201890. Beningn Multiple Sklerozda Uyku Bozukluklarının Sıklığı ve İlişkili İmmün Sistem Genlerinin Ekspresyon Düzeyleri
Küçükali C. İ., Karadeniz D., Tüzün E.
54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Unpublished)
2018
201891. Optik Sinir ve Omurilik Tutulumu olan Multiple Skleroz Hastalarının Sitokin-Kemokin Düzeyi ve Bilişsel Profili
Küçükali C. İ., Yılmaz V., Tüzün E.
54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Unpublished)
2018
201892. Kronik KriptojenikFokal Epilepsi Olgularında Hastalığa Özgü Aday Otoantijen Yaklaşımı
Küçükali C. İ., Gezen Ak D., Dursun E., Kasap M., Akpınar G., Sezgin M., et al.
54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Unpublished)
2018
201893. Multiple Skleroz Patofizyolojisinde Perisitlerin Rolünün Deneysel Allerjik Ensefalomyelit Modelinde İncelenmesi
Küçükali C. İ., Ulusoy C. A., Tüzün E., Özdemir Y.
54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Unpublished)
2018
201894. İdiyopatik İntrakraniyal Hipertansiyonda Antinöronal Membran Antikorlar
Küçükali C. İ., Gezen Ak D., Dursun E., Kasap M., Akpınar G., Baykal B., et al.
54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Unpublished)
2018
201895. Fokal Epilepsilerde İnflamazomun Rolü
Küçükali C. İ., Ulusoy C. A., Bebek N., Tüzün E., Baykal B.
54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Unpublished)
2018
201896. Optik sinir ve omurilik tutulumu olan multipl skleroz hastalarının sitokin-kemokin düzeyi ve bilişsel profili
Şen M., Ece A., MERCAN Ö., Arsoy E., YILMAZ V., Gencer M., et al.
54. Ulusal Nöroloji Kongresi, Turkey, 1 - 05 December 2018, (Full Text)
2018
201897. Multipl sklerozda hipotalamus ve pineal beze ait mediyatör düzeylerinin hastalık progresyonu ve motor sistem performansı ile ilişkisi
Akbayır E., Şen M., Arsoy E., ULUSOY C. A., YILMAZ V., TÜZÜN E., et al.
54. Ulusal Nöroloji Kongresi, Turkey, 1 - 05 December 2018, (Full Text)
2018
201898. Bilgisayarlı Kognitif Rehabilitasyonun Benign Multipl Sklerozda Yürütücü İşlevlere Etkisi
Akbayır E., Şen M., ŞANLI E., Arsoy E., Türkoğlu R., TÜZÜN E.
54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 01 December 2018 - 06 September 2019, pp.1, (Summary Text)
2018
201899. Is the frequency of neuronal autoantibodies higher in patients with bilateral hippokampal sclerosis compared to unilateral ones?
Küçükali C. İ., Tüzün E., Sezgin M., Ulusoy C. A., Bebek N., Sencer N. S., et al.
13th European Congress on Epileptology, Vienna, Austria, 26 - 30 August 2018, (Unpublished)
2018
2018100. Circulating B cell subsets in chronic inflammatory demyelinating polyneuropaty
ÖZDAĞ ACARLI A. N., YILMAZ V., Şirin İnan N. G., Soysal A., aysal f., DURMUŞ TEKÇE H., et al.
4th Congress of the European Academy of Neurology, 16 - 19 June 2018, (Full Text)
2018
2018101. Computerised cognitive rehabilitation improves executive functions in benign Multiple Sclerosis patients
TÜZÜN E., Arsoy E., Turkoglu R.
4th Congress of the European-Academy-of-Neurology (EAN), Lisbon, Portugal, 16 - 19 June 2018, vol.25, pp.563, (Summary Text)
2018
2018102. Optikospinal multipl sklerozun sitokin profilinin incelenmesi
Şen M., akbayır E., MERCAN Ö., Erdil A., TÜRKOĞLU R., YILMAZ V., et al.
16. Ulusal Sinirbilim Kongresi, Turkey, 20 - 23 May 2018, (Full Text)
2018
2018103. Parkinson Hastalığında Mikroarray Ekspresyon Verilerinin Biyoinformatik Yöntemlerle İncelenmesi
Küçükali C. İ., Timirci Kahraman Ö., Tüzün E., Ulusoy C. A., Ergen H. A.
Nörodejenerasyon / Nörorejenerasyon Çalıştayı, İstanbul, Turkey, 4 - 05 May 2018, (Unpublished)
2018
2018104. SEPSİS İLİŞKİLİ AKUT BEYİN DİSFONKSİYONU OLAN HASTALARDA İNFLAMATUAR BELİRTEÇLER İLE KOGNİTİF SONUÇ İLİŞKİSİ
ORHUN G., TÜZÜN E., ERGİN ÖZCAN P., ULUSOY C. A., YILDIRIM E., KÜÇÜKERDEN M., et al.
19.Ulusal Yoğun Bakım Kongresi, Turkey, 19 - 22 April 2018, vol.22, (Summary Text)
2018
2018105. Novel anti-neuronal antibodies in idiopathic intracranial hypertension patients
Tuzun E., Altiokka-Uzun G., Erdag E., Gezen-Ak D., Dursun E., Kucukali C. I., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)
2018
2018106. P015 Association between inflammatory markers and cognitive outcome in patients with acute brain dysfunction due to sepsis
ORHUN G., TÜZÜN E., ERGİN ÖZCAN P., ULUSOY C. A., YILDIRIM E., KÜÇÜKERDEN M., et al.
38th International Symposium on Intensive Care and Emergency Medicine, 20 - 23 March 2018, vol.22, pp.87, (Summary Text)
2018
2018107. Association between inflammatory markers and cognitive outcome in patients with acute brain dysfunction due to sepsis
Orhun G., Tüzün E., Ergin Özcan P., Ulusoy C. A., Küçükerden M., Gürvit İ. H., et al.
. 38th International Symposium on Intensive Care and Emergency Medicine , Brussels, Belgium, 20 - 23 March 2018, pp.7, (Summary Text)
2017
2017108. Topiramatın Fare Frenik Sinir-Hemidiyafram Preparatı Üzerine Etkileri
Küçükali C. İ., Yüceer H., Tüzün E.
53. Ulusal Nöroloji Kongresi, Antalya, Turkey, 24 - 30 November 2017, pp.298, (Summary Text)
2017
2017109. Kronik İnflamatuar Demiyelinizan Polinöropati’de Periferik Kan B hücre İmmünfenotiplemesi
YILMAZ V., Şirin İnan N. G., Soysal A., aysal f., DURMUŞ TEKÇE H., TÜZÜN E., et al.
53. Ulusal Nöroloji Kongresi, Turkey, 24 - 30 November 2017, (Summary Text)
2017
2017110. NEDENİ BELİRLENEMEYEN EPİLEPTİK ENSEFALOPATİLERDE OTOİMMUN ANTİKORLARIN ARAŞTIRILMASI
Tektürk P., Baykal B., Erdağ E., Sezgin M., Küçükali C. İ., Yapıcı Z., et al.
53. Ulusal Nöroloji Kongresi, Antalya, Turkey, 24 - 30 November 2017, pp.13, (Summary Text)
2017
2017111. Hafıza B hücre Düzeyi Klinik İzole Sendrumun Multipl Skleroza Dönüşümü için Biyobelirteç Olabilir mi?
TÜZÜN E., AK TURA D., YILMAZ V., Özkan Yaşargün D., TÜRKOĞLU R.
53. Ulusal Nöroloji Kongresi, Turkey, 24 - 30 November 2017, (Summary Text)
2017
2017112. Multipl skleroz gelişiminde aday biyomarkerlarin proteomiks analiz yöntemi ile belirlenmesi
TİMİRCİ KAHRAMAN Ö., KARAASLAN Z., KÜÇÜKALİ C. İ., TÜZÜN E., BAYKAL A. T., KÜRTÜNCÜ M., et al.
53. ulusal nöroloji kongres, Turkey, 24 - 30 November 2017, (Summary Text)
2017
2017113. Selective inhibition of purinergic 2X7 receptors elicits antidepressant-like effect in chronic mild stress model in rats: role of innate immunity
Aricioglu F., Ozkartal C. S., Bastaskin T., Tuzun E., Kucukali C., Utkan T.
30th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Paris, France, 2 - 05 September 2017, vol.27, (Summary Text)
2017
2017114. The NLRP1 and NLRP3 inflammasomes are activated in multiple sclerosis and clinically isolated syndrome
Turkoglu R., Ozkan-Yasargun D., TÜZÜN E.
3rd Congress of the European-Academy-of-Neurology, Amsterdam, Netherlands, 01 June 2017, vol.24, pp.415, (Summary Text)
2017
2017115. Prognostic value of adipokines in multiple sclerosis
TÜZÜN E., Duzel B., Turkoglu R., Tamam Y.
3rd Congress of the European-Academy-of-Neurology, Amsterdam, Netherlands, 01 June 2017, vol.24, pp.416, (Summary Text)
2017
2017116. GABA and microbiota association in multiple sclerosis and neuro-Behcet's disease
Oezguen N., Yalcinkaya N., KÜÇÜKALİ C. İ., Dahdouli M., Hollister-Branton E., Luna R. A., et al.
3rd Congress of the European-Academy-of-Neurology, Amsterdam, Netherlands, 01 June 2017, vol.24, pp.656, (Summary Text)
2017
2017117. MuSK binding peripheral B cells as biomarker for MuSK myasthenia gravis
TÜZÜN E.
13th International Conference on Myasthenia Gravis and Related Disorders, New York, United States Of America, 15 - 17 May 2017, vol.1, pp.12, (Full Text)
2017
2017118. Cytokine Production in Myasthenia Gravis
YILMAZ V., OFLAZER P., aysal f., DURMUŞ TEKÇE H., PARMAN F. Y., TÜZÜN E., et al.
13th International Conference on Myasthenia Gravis and Related Disorders, 15 - 17 May 2017, (Summary Text)
2017
2017119. ŞİZOFRENİ HASTALARI VE KARDEŞLERİNDE KİNÜRENİN YOLAĞI METABOLİTLERİ, VİTAMİN D VE İNFLAMASYON BELİRTEÇLERİNİN KOGNİSYON VE KLİNİK BELİRTİLERLE İLİŞKİSİ
Noyan H., TÜZÜN E., Erdağ E., HAKAN M. T., KÜÇÜKHÜSEYİN Ö., YAYLIM İ., et al.
II. Türkiye in vitro Diyagnostik(IVD)Sempozyumu, İzmir, Turkey, 10 - 22 May 2017, pp.1, (Full Text)
2017
2017120. Immune Cell Infiltration in CASPR2-Antibody Associated Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis
TÜZÜN E., YAVUZ E. N., ERDAĞ E., BAYKAL B.
Neurology, United States Of America, 18 - 22 April 2017, vol.88, pp.1226, (Summary Text)
2017
2017121. Nöronal Oto-antikorlarla İlişkili Dirençli Epilepsi Olgularında Otoimmun Tedavi Deneyimi ve EEG Üzerine Etkisi
Sezgin M., Ekizoğlu Turgut E., Tüzün E., Erdağ E., Bebek N., Gürses R. C., et al.
33. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Antalya, Turkey, 12 - 16 April 2017, pp.104, (Summary Text)
2016
2016122. Fingolimod Tedavisinin Multipl Skleroz hastalarında periferik kan hücre immünofenotipleri üzerine etkisi
AKÇAY H. İ., ULUSOY C. A., ÇINAR S., YILMAZ V., Türkoğlu R., Altunrende B., et al.
52. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Turkey, 25 November - 01 December 2016, pp.30, (Full Text)
2016
2016123. Fingolimod Tedavisinin Multipl Skleroz Hastalarında Periferik Kan hücre İmmunufenotipleri üzerine Etkisi
AKÇAY H. İ., ULUSOY C. A., ÇINAR S., YILMAZ V., TÜRKOĞLU R., ALTUNRENDE B., et al.
52. Ulusal Nöroloji Kongresi, Turkey, 25 November - 01 December 2016, (Summary Text)
2015
2015124. Anti NMDA receptor encephalitis with cancer of unknown primary origin
TÜZÜN E., ÇOBAN A., TÜRKOĞLU R., BİLGİÇ B.
1st Congress of the European-Academy-of-Neurology, 20 June 2015
2016
2016125. Heat shock proteins in a rat model of pyelonephritis and renal scar
Yılmaz A., Yürük Yıldırım Z. N., Küçük M., Gedikbaşı A., Pehlivanoğlu C., Özlük M. Y., et al.
17th IPNA Congress,, Iguatu, Brazil, 20 - 24 September 2016, vol.31, pp.1765-1983, (Full Text)
2016
2016126. Detection Of Biomarkers in Cerebrospinal Fluid of Multiple Sclerosis Patients By Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
TİMİRCİ KAHRAMAN Ö., KÜÇÜKALİ C. İ., TÜZÜN E., KÜRTÜNCÜ M., BAYKAL A. T., ERAKSOY M.
X. Annual Congress of the European Proteomics Association, İstanbul, Turkey, 22 - 25 June 2016, pp.1-2, (Full Text)
2016
2016127. The effect of fingolimod treatment on peripheral blood cell immunophenotypes in patients with multiple sclerosis
ULUSOY C. A., ÇINAR S., YILMAZ V., AKÇAY H. İ., Türkoğlu R., GÜNDÜZ T., et al.
International Molecular Immunology & Immunogenetcs Congress (MIMIC-III), Antalya, Turkey, 27 - 30 April 2016, vol.4, pp.75, (Full Text)
2016
2016128. A Proteomics Approach for the Identification of Cerebrospinal Fluid Proteins Associated with Conversion to Multiple Sclerosis
Kurtuncu M., Turkoglu R., Tuzun E., Kucukali C.
68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text)
2016
2016129. Different Cognitive Parameters in Bilateral and Unilateral Hippocampal Sclerosis
Yavuz E. N., Bilgic B., Tuzun E., Sencer S., Sencer A., Bebek N., et al.
68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text)
2016
2016130. Switching From Glatiramer Acetate: Comparison of Disease Modifying Treatments
Kurtuncu M., Akcay H. I., Cakar A., Gunduz T., Tuzun E., Eraksoy M.
ACTRIMS Forum, Louisiana, United States Of America, 18 - 20 February 2016, vol.22, pp.18-19, (Summary Text)
2016
2016131. Clinical features of patients with relapsing inflammatory optic neuritis
Tuzun E., Cakar A., Akcay H. I., Kurtuncu M., Eraksoy M.
ACTRIMS Forum, Louisiana, United States Of America, 18 - 20 February 2016, vol.22, pp.20-21, (Summary Text)
2015
2015132. Idiopatik Intrakranial Hipertansiyon Olgularında Serum Nöron Spesifik Enolaz Düzeylerinin Incelenmesi.
ŞAHİN E., SAMANCI B., Samancı Y., Altıokka Uzun G., EKİZOĞLU TURGUT E., İÇÖZ S., et al.
51. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 03 December 2015, pp.1, (Full Text)
2015
2015133. Tümefaktif Multipl Sklerozda Serum İyon Kanalı Antikorları
TÜRKOĞLU R., ÇOBAN A., AKCAN U., ULUSOY C. A., ÇEVİK D., ÖZYURT S., et al.
51. Ulusal Nöroloji Kongresi, Turkey, 27 November 2015
2015
2015134. PİLOMOTOR NÖBETLER VE PSİKOZLA GİDEN TEMPORAL LOB EPİLEPSİLİ OLGUDA İLK KEZ SAPTANAN GABA-A RESEPTÖRÜNE KARŞI OTO-ANTİKORLAR
Sezgin M., Tüzün E., Baysal Kıraç L., Vanlı Yavuz E. N., Bebek N., Gürses C., et al.
51. ULUSAL NÖROLOJİ KONGRESİ , Antalya, Turkey, 27 November - 03 December 2015, pp.133, (Summary Text)
2015
2015135. Parkinson Hastalıgının Etyopatogenesinde Kanser Yollarının Rolü.
Yalçınkaya N., Haytural H., KÜÇÜKALİ C. İ., GÜRVİT İ. H., HANAĞASI H. A., BİLGİÇ B., et al.
7. DETAE Günleri, İstanbul, Turkey, 11 - 12 November 2015, pp.1, (Full Text)
2015
2015136. MUSK INDUCED EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS IS ANTI-MUSK IGG1 INDEPENDENT
Kucukerden M., Huda R., TÜZÜN E., Strait R. T., Finkelman F. D., Trakas N., et al.
American-Association-of-Neuromuscular-and-Electrodiagnostic-Medicine 62nd Annual Meeting, Hawaii, United States Of America, 28 - 31 October 2015, vol.52, (Summary Text)
2015
2015137. In vivo, in vitro and behavioural effects of intracerebral injection of neuro-Behcet's disease immunoglobulin and sera to brain parenchyma
ERDAG E., ŞAHİN C., Tuzun E., Kucukali C. I., ARICIOĞLU F.
28th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Amsterdam, Netherlands, 29 August - 01 September 2015, vol.25, (Summary Text)
2015
2015138. Impact of intracerebral neuro-Behcet's disease immunoglobulin injection to brain parenchyma histology and behavioral tests
Erdag E., Sahin C., Aricioglu F., Turkoglu R., Tuzun E.
1st Congress of the European-Academy-of-Neurology, Berlin, Germany, 20 - 23 June 2015, vol.22, pp.527, (Summary Text)
2015
2015139. Effects of GNAS1 T393C and GNB3 C825T polymorphisms on schizophrenia.
Gökçe H. H., KÜÇÜKALİ C. İ., DAŞDEMİR S., TÜZÜN E., ÇAKMAKOĞLU B.
V. International Congress of Molecular Medicine, İzmir, Turkey, 20 - 22 May 2015, pp.1, (Full Text)
2015
2015140. Investigation of DNA repair genes in patients with obsessive compulsive disorder.
Çelik R., KÜÇÜKALİ C. İ., Bireller E. S., TÜZÜN E., ÇAKMAKOĞLU B.
V. International Congress of Molecular Medicine, İzmir, Turkey, 20 - 22 May 2015, pp.1, (Full Text)
2015
2015141. Evaluation of Paraoxonase 1 Polymorphisms in Patient with Bipolar Disorder.
ULUSOY C. A., Özden Ö., Güleç H., TÜZÜN E., KÜÇÜKALİ C. İ.
V. International Congress of Molecular Medicine, İzmir, Turkey, 20 - 22 May 2015, pp.1, (Full Text)
2015
2015142. Chemokine gene variants in schizophrenia.
DAŞDEMİR S., KÜÇÜKALİ C. İ., Bireller E. s., TÜZÜN E., ÇAKMAKOĞLU B.
20th International Conference Association of Psychology & Psychiatry for Adults & Children, Atina, Greece, 18 - 22 May 2015, pp.1, (Full Text)
2013
2013143. Multipl Sklerozda Erken Dönem Serum Sitokin Düzeyleri Değişiminin Uzun Süreli İnterferon Beta1a Kullanım Etkinliği Üzerinde Tahmin Ettirici Rolü Var mıdır
ÇOBAN A., BALCI B., SHUGAİV E., TÜRKOĞLU R., ULUSOY C. A., İÇÖZ S., et al.
49. Ulusal Nöroloji Kongresi, Turkey, 11 November 2013
2015
2015144. Reduced serum vitamin D levels in neuromyelitis optica
TÜZÜN E., Küçükhüseyin Ö., KÜRTÜNCÜ M., TURKOGLU R., YAYLIM İ.
EACR Neurological Sciences, İzmir, Turkey, 25 April 2015, pp.1-2, (Summary Text)
2015
2015145. Serum antibodies isolated from neuro-Behcet’s disease patients mediate neuronal death and cognitive impairment.
TÜZÜN E., Erdağ E., Şahin C., KÜÇÜKALİ C. İ., KAYA M., KÜRTÜNCÜ M., et al.
AAN 67th Annual Meeting, Vancouver, Canada, 18 - 25 April 2015, pp.1, (Full Text)
2013
2013146. Üveitin Multipl Sklerozun Seyri Üzerine Etkisi
SHUGAİV E., TÜZÜN E., ÇOBAN A., PEHLİVAN M., KÜRTÜNCÜ M., DEMİR G., et al.
49. Ulusal Nöroloji Kongresi, Turkey, 11 November 2013
2013
2013147. Uveitis as a prognostic factor in multiple sclerosis
Shugaiv E., TÜZÜN E., ÇOBAN A., Pehlivan M., KÜRTÜNCÜ M., Demir G., et al.
29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 October 2013
2014
2014148. Nöromiyelitis Optika ve Otoimmün Ensefalitte Serum Oreksin A düzeyleri
ÇOBAN A., KÜÇÜKALİ C. İ., HAYTURAL H., BENBİR G., ULUSOY C. A., GİRİŞ M., et al.
50. Ulusal Nöroloji Kongresi, Turkey, 21 November 2014
2014
2014149. Nöro Behçet Hastalığının Aktif ve İnaktif Dönemlerindeki Gen Ekspresyon Profilleri
UĞUREL E., ŞEHİTOĞLU E., KÜRTÜNCÜ M., TÜZÜN E., SHUGAİV E., ÇOBAN A., et al.
6. DETAE Günleri, Turkey, 24 November 2014
2014
2014150. Anti nöronal Antikora Sahip Hastaları Prognozu
ÇELİK Ş., TÜZÜN E., DEMİR G., ÇOBAN A., İÇÖZ S., BİRDAY E., et al.
50. Ulusal Nöroloji Kongresi, Turkey, 21 November 2014
2014
2014151. Nöromyelitis Optika ve Otoimmün Ensefalitte Serum Oreksin-A Düzeyleri.
Çoban A., Küçükali C. İ., Haytural H., Benbir Şenel G., Ulusoy C. A., Giriş M., et al.
50. Ulusal Nöroloji Kongresi, Antalya, Turkey, 21 - 27 November 2014, pp.1, (Full Text)
2014
2014152. Parkinson Hastalıgı’nın Hayvan Modelinde P13K/AKT Yolagı Ile Mitokondriyal, Oksidatif ve Apoptotik Parametrelerinin Iliskisi.
Yalçınkaya N., Haytural H., Türkoğlu R., KÜÇÜKALİ C. İ., TÜZÜN E.
50. Ulusal Nöroloji Kongresi, Antalya, Turkey, 21 - 27 November 2014, pp.28-37, (Full Text)
2014
2014153. Beyin Parankimal Histolojisi Üzerine Intraserebral Nöro- Behçet IgG ve Serum Enjeksiyonu Etkisi.
Erdağ E., şahin c., KÜÇÜKALİ C. İ., Arıcıoğlu F., TÜZÜN E.
50. Ulusal Nöroloji Kongresi, Antalya, Turkey, 21 - 27 November 2014, pp.103, (Full Text)
2014
2014154. Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients
Tuzun E., Ulusoy C. A., Turan S., Orcen A., Yetimler B., Akbas-demir D., et al.
12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 9 - 13 November 2014, vol.275, pp.228, (Summary Text)
2014
2014155. Antibodies to DNA repair proteins in HaNDL patients
Erdag E., Tuzun E., Kurtuncu M., Vural B.
12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 9 - 13 November 2014, vol.275, pp.59, (Summary Text)
2014
2014156. Investigation of the impact of intravenous injection of mesenchymal stem cells from mouse bone marrow on muscle weakness and immunological parameters in experimental autoimmune myasthenia gravis model
Ulusoy C. A., Kucukerden M., Turan S., Gurkan G., ÖĞÜLÜR İ., AKKOÇ T., et al.
12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 9 - 13 November 2014, vol.275, pp.195, (Summary Text)
2014
2014157. Differential cytokine changes in myasthenia gravis patients with antibodies against AChR and Musk
Yilmaz V., Oflazer P., Aysal F., Durmus H., Poulos K., Parman Y., et al.
12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 9 - 13 November 2014, vol.275, pp.212-213, (Summary Text)
2014
2014158. A novel predictive factor, sorcin antibody in conversion of radiologically isolated syndrome to multiple sclerosis
Erdag E., Sehitoglu E., Kucukerden M., Orcen A., Tuzun E., Turkoglu R.
12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 9 - 13 November 2014, vol.275, pp.17-18, (Summary Text)
2014
2014159. Evaluation of Incidence and Clinical Features of Antibody Associated Autoimmune Encephalitis Mimicking Dementia.
Erdağ E., ÇOBAN A., KÜÇÜKALİ C. İ., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H., et al.
Alzheimer’ s Association International Conference, Copenhagen, Denmark, 12 - 17 July 2014, pp.1, (Full Text)
2014
2014160. A Preliminary Study: The effect of Vitamin D3 on mitotic index of SH-SY5Y Neuroblastoma Cells"
YAYLIM İ., KÜÇÜKHÜSEYİN Ö., ÇAKİRİS A., Haytural H., ÜSTEK D., TÜZÜN E.
17. Workshop on Vitamin D, Chicago, United States Of America, 17 - 20 June 2014, pp.1, (Full Text)
2013
2013161. Mitochondrial carrier 1 (MTCH1) antibodies in neuromyelitis optica patients with or without aquaporin-4 antibodies
Coban A., Cavus F., Ulusoy C., Turan S., Vural B., Turkoglu R., et al.
6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japan, 6 - 08 November 2013, vol.20, pp.942-943, (Summary Text)
2013
2013162. Cerebral white matter lesions in Behcet's disease: neuro-Behcet's disease or multiple sclerosis?
Akman-Demir G., Mutlu M., Kiyat-Atamer A., Shugaiv E., KÜRTÜNCÜ M., Tugal-Tutkun I., et al.
6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japan, 6 - 08 November 2013, vol.20, pp.948-949, (Summary Text)
2014
2014163. Coexistence of neuromyelitis optica and seizures a case report
SHUGAİV E., ÇOBAN A., KÜRTÜNCÜ M., TÜZÜN E., DEMİR G., ERAKSOY M.
EFNS-ENS Joint Congress of European Neurology, 31 May 2014
2014
2014164. Gene expression profiles in neuro Behcet s disease during active and inactive stages
UĞUREL E., ŞEHİTOĞLU E., KÜRTÜNCÜ M., SHUGAİV E., ULUSOY C. A., KÜÇÜKERDEN M., et al.
EFNS-ENS Joint Congress of European Neurology, 31 May 2014
2014
2014165. Demansı Taklit Eden Antikor Iliskili Otoimmün Ensefalitin Insidansının ve Klinik Özelliklerinin Degerlendirilmesi.
Erdağ E., KÜÇÜKALİ C. İ., TÜZÜN E., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H.
12. Ulusal Sinirbilimleri Kongresi, İstanbul, Turkey, 28 - 31 May 2014, pp.1, (Full Text)
2014
2014166. Gene expression profiles in neuro-Behcet's disease during active and inactive stages
Ugurel E., Sehitoglu E., KÜRTÜNCÜ M., Shugaiv E., ULUSOY C. A., Kucukerden M., et al.
Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, (Summary Text)
2014
2014167. Relatively benign course in the long term follow-up of two cases with epilepsy associated with NMDAR-antibody positivity
Kirac L. B., Turgut E. E., TÜZÜN E., Baykan B.
Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)
2014
2014168. Evaluation of incidence and clinical features of antibody associated autoimmune encephalitis mimicking dementi
ERDAĞ E., ÇOBAN A., KÜÇÜKALİ C., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H., et al.
Alzheimer’s Association International Conference, 12 July 2014
2013
2013169. Aquaporin 1 in Turkish Neuromyelitis Optica Patients with and without Aquaporin 4 Antibodies
ÇOBAN A., Tzartos J., Stergiou C., Demir G., Zisimopoluou P., Shugaiv E., et al.
29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 October 2013
2013
2013170. Aquaporin 1 antikoru Aquaporin 4 Antikoru pozitif olan ve olmayan Nöromyelitis Optica Hastalarında Yeni Saptanan Bir Antikor
ÇOBAN A., TZARTOS J., STERGİOU C., DEMİR G., ZİSİMOPOULOU P., SHUGAİV E., et al.
49. Ulusal Nöroloji Kongresi, Turkey, 15 November 2013
2013
2013171. Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients
KÜRTÜNCÜ M., TÜZÜN E., Balcı B., Birday E., ÇOBAN A., Türkoğlu R., et al.
29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 October 2013
2013
2013172. Uveitis as a prognostic factor in multiple sclerosis
Shugaiv E., Tuzun E., Coban A., Pehlivan M., Kurtuncu M., Tugal-Tutkun I., et al.
29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Denmark, 2 - 05 October 2013, pp.352, (Summary Text)
2013
2013173. Serum anti neuronal antibodies in Amyotrophic Lateral Sclerosis
Türkoğlu R., ÇOBAN A., ULUSOY C. A., Giriş M., Turan S., TÜZÜN E., et al.
Twenty-third Meeting of the European Neurological Society, 08 June 2013
2013
2013174. Amyotrofik Lateral Skleroz ALS da Serum Anti Nöronal Antikorları
TURAN S., ULUSOY C. A., ÇOBAN A., GİRİŞ M., KÜÇÜKERDEN M., TÜRKOĞLU R., et al.
11. Ulusal Sinirbilim Kongresi (11th Turkish Neuroscience Congress), Turkey, 28 April 2013
2013
2013175. MTCH1 antibodies in Neuromyelitis Optica patients with or without aquaporin 4 antibodies
ÇOBAN A., Çavuş F., ULUSOY C. A., Turan S., VURAL B., Türkoğlu R., et al.
Twenty-third Meeting of the European Neurological Society, 08 June 2013
2013
2013176. Ion channel and synapse antibodies for differential diagnosis of chronic neurodegenerative and psychiatric disorders.
Yalçınkaya N., Yalçınkaya N., Haytural H., ULUSOY C. A., Turan S., Küçükerden M., et al.
4th International Medical Students’ Research Congress, İstanbul, Turkey, 3 - 05 May 2013, pp.1, (Full Text)
2013
2013177. Klinik İzole Sendromdan Klinik Olarak Kesin Multipl Skleroza Dönüşüm Sürecinde MRI Ve Disabilitenin Prediktif Değeri
ARIKANOĞLU A., SHUGAİV E., ÇOBAN A., TÜZÜN E., ERAKSOY M.
6. Nöroimmünoloji Okulu, Turkey, 28 February 2013
2013
2013178. Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
Cavus F., Ugurel E., Sehitoglu E., Woodhall M., Waters P., Ulusoy C., et al.
65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, vol.80, (Summary Text)
2013
2013179. Arterial CNS Involvement in Behcet's Disease
Akman-Demir G., Birday-Shugaiv E., Kurtuncu M., Mutlu M., Barlas-Yesilot N., Tuzun E., et al.
65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, (Summary Text)
2012
2012180. Skeletal muscle pathology in the experimental animal model of muscle-specific receptor tyrosine kinase (MuSK) related myasthenia gravis
Ulusoy C., Yilmaz V., Trakas N., Poulas K., Armagan H., Turan S., et al.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, United States Of America, 4 - 08 November 2012, vol.253, pp.51-52, (Summary Text)
2012
2012181. Switch-associated protein 70 (SWAP 70) antibody levels are associated with clinical relapse in multiple sclerosis
Erdag E., Tuzun E., Akman-Demir G., Ugurel E., Sehitoglu E., Cavus F., et al.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, United States Of America, 4 - 08 November 2012, vol.253, pp.17, (Summary Text)
2012
2012182. Uveitis in patients with multiple sclerosis
Shugaiv E., KÜRTÜNCÜ M., Mutlu M., Akman-Demir G., Tugal-Tutkun I., TÜZÜN E., et al.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, United States Of America, 4 - 08 November 2012, pp.34, (Summary Text)
2012
2012183. Elevated Switch-Associated Protein 70 (SWAP70) Antibody Levels during Attacks in Multiple Sclerosis Patients
Erdag E., Ugurel E., Cavus F., Vural B., Kurtuncu M., Eraksoy M., et al.
64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, United States Of America, 21 - 28 April 2012, vol.78, (Summary Text)
2012
2012184. White Matter Lesions in Behcet's Disease: Neuro-Behcet's Disease or Multiple Sclerosis?
Akman-Demir G., Mutlu M., Kiyat-Atamer A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.
64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, United States Of America, 21 - 28 April 2012, vol.78, (Summary Text)
2011
2011185. Anti-Neuronal and Stress-Induced-Phosphoprotein 1 Antibodies in Neuro-Behcet's Disease
Akman-Demir G., Vural B., Ugurel E., Icoz S., TÜZÜN E., Kurtuncu M., et al.
63rd AAN Annual Meeting, Hawaii, United States Of America, 9 - 16 April 2011, vol.76, (Summary Text)
2010
2010186. Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): Could It Be an Autoimmune Disease?
Akman-Demir G., Tuezuen E., KAYA D., Vural B., Ugurel E., Icoez S., et al.
62nd Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 10 - 17 April 2010, (Summary Text)
2009
2009187. Increased complement activation in MuSK-antibody positive myasthenia gravis patients.
YILMAZ V., TÜZÜN E., OFLAZER P., PARMAN F. Y., DEYMEER F., SARUHAN DİRESKENELİ G.
International Conference on Myasthenia, 1 - 02 December 2009, (Summary Text)
2009
2009188. MUSK Antikoru Pozitif Myasthenia Gravis’de Artmış Kompleman Aktivasyonu
YILMAZ V., TÜZÜN E., PARMAN F. Y., DEYMEER F., SARUHAN DİRESKENELİ G.
20. Ulusal İmmünoloji Kongresi, Turkey, 19 - 22 November 2009, (Summary Text)
2008
2008189. Devic's neuromyelitis optica: An analysis of 47 patients and prognostic implications of NMO IgG status
Akman-Demir G., ERAKSOY M., TÜZÜN E., Jarius S., Icoz S., Kartuncu M., et al.
60th Annual Meeting of the American-Academy-of-Neurology, Illinois, United States Of America, 12 - 19 April 2008, vol.70, (Summary Text)
2007
2007190. Clinical and Pathollogical analyzis of paraneoplastic anti-NMDA receptor encephalitis in 16 patients
TÜZÜN E., Rossi J. E., Rosenfeld M. R., Lynch D. R., Dalmau J.
59th Annual Meeting of the American-Academy-of-Neurology, Massachusetts, United States Of America, 28 April - 05 May 2007, vol.68
2007
2007191. Adenylate kinase 5 (AK5) autoimmunity in limbic encephalitis
TÜZÜN E., Rossi J. E., Karner S. F., Centurion A. F., Dalmau J.
59th Annual Meeting of the American-Academy-of-Neurology, Massachusetts, United States Of America, 28 April - 05 May 2007, vol.68, (Summary Text)
2006
2006192. Functional NR2B and NR2A heteromers of the NMDA receptor are the autoantigens of treatment-responsive encephalitis in patients with ovarian teratoma
Dalmau J., TÜZÜN E., Wu HY W. H., Rossie J. E., Maronski M., Masjuan J., et al.
131st Annual Meeting of the American-Neurological-Association, Illinois, United States Of America, 8 - 11 October 2006, vol.60, pp.639-640, (Summary Text)
2006
2006193. Plasma cytokine levels in juvenile myasthenia gravis: 11 patients
Yapici Z., Erdogan H. A., TÜZÜN E., Vildan A., İŞSEVER H., ERAKSOY M.
11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)
2006
2006194. HLA class II molecules and AChR subunit immunity determine ocular myasthenia gravis susceptibility in HLA transgenic mice
Christadoss P., Bednov A., Saini S., TÜZÜN E., Yang H.
58th Annual Meeting of the American-Academy-of-Neurology, California, United States Of America, 1 - 08 April 2006, vol.66, (Summary Text)
2006
2006195. Anti-DAF antibody administration augments the development of ocular myasthenia gravis in HILA-DQ8 transgenic mice
Li F., TÜZÜN E., Saini S. S., Bednov A., Harris C. L., Christadoss P.
131st Annual Meeting of the American-Neurological-Association, Illinois, United States Of America, 8 - 11 October 2006, vol.60
2004
2004196. Anti-C1q antibody treatment prevents murine myasthenia gravis by reducing IL-5 and IFN-gamma production and neuromuscular junction complement deposition
Christadoss P., TÜZÜN E., Saini S., Yang H.
20th International Complement Workshop, Hawaii, United States Of America, 13 - 18 June 2004, vol.41, pp.221, (Summary Text)
2004
2004197. A pilot trial of etanercept in the treatment of steroid-dependent, generalized autoimmune myasthenia gravis
Rowin J., Meriggioli M., TÜZÜN E., Christadoss P.
56th Annual Meeting of the American-Academy-of-Neurology, San-Francisco, Costa Rica, 24 April - 01 May 2004, vol.62, (Summary Text)
2001
2001198. Morvan's syndrome: New insights into the mechanisms of thalamic insomnia
Tüzün E.
Journal of Neurological Sciences, İstanbul, Turkey, 01 August 2001, vol.18, pp.1, (Full Text)
Books
2025
20251. Current Biomarkers in Multiple Sclerosis Treatment
Türkoğlu R. (Editor), Tüzün E. (Editor)
Türkiye Klinikleri Yayınevi, Ankara, 2025
2025
20252. Preface
Türkoğlu R. (Editor), Tüzün E. (Editor)
in: Current Biomarkers in Multiple Sclerosis Treatment, Recai Türkoğlu,Erdem Tüzün, Editor, Türkiye Klinikleri Yayınevi, Ankara, 2025
2025
20253. Treatment Response Markers of Flow Cytometry Method in Ocrelizumab Treatment
Akbayır E., Tüzün E. (Editor)
in: Current Biomarkers in Multiple Sclerosis Treatment, Recai Türkoğlu,Erdem Tüzün, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.10-16, 2025
2025
20254. The Predictive Role of Biomarkers in Monitoring Aggressive Multiple Sclerosis
Erol Yıldız R., Tüzün E.
in: Current Biomarkers in Multiple Sclerosis Treatment, Recai Türkoğlu,Erdem Tüzün, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.31-37, 2025
2024
20245. Neuroscience for neurologists
Yemişci Özkan M. (Editor), Karataş Kurşun H. (Editor), Küçükali C. İ. (Editor), Tüzün E. (Editor), Baştan B. (Editor)
Bayçınar, Ankara, 2024
2024
20246. IgG4 autoantibodies in the context of IgG4 autoimmunity
Huijbers M. G., Koneczny I. (Editor), YILMAZ V. (Editor), TÜZÜN E. (Editor), Querol L. (Editor), Martinez P. (Editor)
Frontiers Media SA., 2024
2024
20247. Neuronal Culture Methods to Study Neuronal Function and Disease
Şen M., Ayşit N., Bay S., Tüzün E.
in: Current Trends in Neurosciences , Nurcan Orhan,Zeynep Karakaş,Tamer Demiralp, Editor, İstanbul Üniversitesi, İstanbul, pp.127-153, 2024
2024
20248. Channels and transporters
Şanlı E., Tüzün E.
in: Neuroscience for neurologists, Yemişci M,Karataş-Kurşun H,Küçükali Cİ,Tüzün E,Baştan B, Editor, Bayçınar, Ankara, pp.97-113, 2024
2024
20249. Synaptic Transmission
Yüceer H., Tüzün E.
in: Neuroscience for Neurologists, Yemişci M,Karataş-Kurşun H,Küçükali Cİ,Tüzün E,Baştan B, Editor, Bayçınar, Ankara, pp.77-85, 2024
2024
202410. The Experimental Animal Models for the Research of Neuroimmunological Diseases
AKBAYIR E., ULUSOY C. A., Cossins J., TÜZÜN E.
in: Current Trends in Neurosciences, ORHAN NURCAN, KARAKAŞ ZEYNEP, DEMİRALP TAMER, Editor, Istanbul University Press, İstanbul, pp.37-61, 2024
2023
202311. Neuroinflammation in the central nervous system
Yüceer H., Tüzün E.
in: Neuroimmunology, Yücesan C,Tuncer A,Uzunköprü C, Editor, Türk Nöroloji Derneği, Ankara, pp.51-65, 2023
2022
202212. Epilepsi ve status epileptikusta inflamatuar mekanizmalar, biyobelirteçler ve tedavi yaklaşımları
Tüzün E.
in: Epilepsi ve Farmakoterapisi Klinik ve Nörobiyolojik Yaklaşım, Dervent A,Yılmaz Onat F,altındag E, Editor, Nobel Tıp Kitapevi, İstanbul, pp.1-15, 2022
2021
202113. Neuro-Behçet’s Disease
Tüzün E. (Editor), Kürtüncü M. (Editor)
Springer, London/Berlin , London, 2021
2021
202114. Neuro-oncology
Tüzün E., Hanağası F., Sabancı P. A., Akman-Demir G., Yazıcı J.
in: İTF Neurology e-book, A. Emre Öge,Betül Baykan,başar bilgiç, Editor, Nobel Yayın Dağıtım, İstanbul, pp.733-757, 2021
2021
202115. Multipl skleroz etiyolojisi
Tüzün E.
in: Multipl Skleroz, Yeşim Beckmann,Cihat Uzunköprü, Editor, Ema Tıp Kitabevi, İstanbul, pp.15-24, 2021
2021
202116. Preface
Tüzün E., Kürtüncü M.
in: Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment, Erdem Tüzün,Murat Kürtüncü, Editor, Springer-Verlag , London, 2021
2021
202117. Neuro-Behçet’s Disease: Epidemiology and Genetics
Yüceer H., Tüzün E.
in: Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment, Erdem Tüzün,Murat Kürtüncü, Editor, Springer-Verlag , London, pp.1-16, 2021
2021
202118. Animal Models of Behçet’s Disease
Yüceer H., Tüzün E.
in: Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment, Erdem Tüzün,Murat Kürtüncü, Editor, Springer-Verlag , London, pp.41-48, 2021
2018
201819. İnfeksiyöz ve inflamatuar epilepsiler
Kınay D., Tezer İ., TÜZÜN E.
in: Epilepsi, Bora İbrahim H, Yeni S Naz, Gürses Candan, Editor, Nobel Yayın Dağıtım, İstanbul, pp.183-222, 2018
2017
201720. Nanotechnology-based management of neurological autoimmune diseases
TÜZÜN E.
in: Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery across the Blood–Brain Barrier, Gürsoy-Özdemir Y, Pehlivan SB, Şekerdağ E, Editor, Elsevier Science, Oxford/Amsterdam , Londra, pp.279-290, 2017
2015
201521. Santral sinir sisteminin nörolojik hastalıkları
Çoban A., TÜZÜN E.
in: Çocukluk ve Adolesan Döneminin Nörolojik Hastalıkları Rehberi, Dervent A, Ayta S, Cokar O, Uluduz D, Editor, Ulusal Nöroloji Derneği, İstanbul, pp.207-213, 2015
2013
201322. Miyastenia gravis modeli
Tüzün E., Ulusoy C. A.
in: Temel ve Klinik Nöroimmünoloji, Karabudak R, Editor, Ada Yayıncılık, İstanbul, pp.165-173, 2013
2013
201323. Paraneoplastik nörolojik sendromlar
Altunrende B., Akman-Demir G., Tüzün E.
in: Temel ve Klinik Nöroimmünoloji, Karabudak R, Editor, Ada Yayıncılık, İstanbul, pp.521-536, 2013
2013
201324. Limbik ensefalit
TÜZÜN E.
in: Temel ve Klinik Nöroimmünoloji, Karabudak R, Editor, Ada Yayıncılık, İstanbul, pp.511-519, 2013
2011
201125. İmmünolojik Mekanizmalı Nörolojik Hastalıklar
Şahin H., TÜZÜN E.
in: Temel Nöroloji, Emre M, Editor, Güneş Yayınları, İstanbul, pp.997-1001, 2011
2011
201126. Kanser hastasının nörolojik sorunları
ERKOL G., TÜZÜN E., SİVA A.
in: Kanser Hastasına Yaklaşım, Molinas Mandel M, Onat H, Editor, Nobel Yayın Dağıtım, İstanbul, pp.275-301, 2011
2011
201127. Paraneoplastik Nörolojik Sendromlar
TÜZÜN E.
in: Temel Nöroloji, Emre M, Editor, Güneş Yayınları, İstanbul, pp.1145-1151, 2011
2010
201028. Targeting classical complement pathway and IL-6 in experimental autoimmune myasthenia gravis.
TÜZÜN E., Christadoss P.
in: Myasthenia Gravis Disease Mechanisms and Immune Intervention, Christadoss P, Editor, Linus Publications, New York, pp.327-351, 2010
2010
201029. Pathogenic mechanisms in myasthenia gravis
TÜZÜN E., Vincent A.
in: Myasthenia Gravis Disease Mechanisms and Immune Intervention, Christadoss P, Editor, Linus Publications, New York, pp.23-39, 2010
2009
200930. Neuromuscular Junction Disorders
TÜZÜN E., Vincent A.
in: Master in Neuroimmunology, Montalban XG, Sastre-Garriga J, Editor, Viguera Editores S.L., Barcelona, pp.275-325, 2009
2009
200931. Nöroonkoloji
TÜZÜN E., Akman-Demir G., Yazıcı J.
in: Nöroloji Ders Kitabı, Öge AE, Baykan B, Editor, -, İstanbul, pp.577-593, 2009
2007
200732. Complement associated pathogenic mechanisms in myasthenia gravis
TÜZÜN E., Christadoss P.
in: Neuroimmunology Research Perspectives, Johansson LM, Editor, Nova Science Publishers, New York, pp.103-129, 2007
Patent
2024
2024Methods using anti-slc3a2 autoantibodies and slc3a2 for detection of glioma brain tumor from patient serum
Patent
Pending / Applied, The Invention Recourse Number: US20240060979A1 , Standard Registration
2022
2022GLİOMA BEYİN TÜMÖRÜNÜN HASTA SERUMLARINDAN TESPİTİNE YÖNELİK ANTİ-SLC3A2 OTOANTİKORLARININ VE SLC3A2'NİN KULLANILDIĞI YÖNTEMLER
Patent
Registered / Approved, The Invention Registration Number: 2020/21768 , Standard Registration
Activities in Scientific Journals
2023 - Present
2023 - PresentPsychiatry and Clinical Psychopharmacology
Committee Member
2022 - Present
2022 - PresentJournal of Multiple Sclerosis Research
Committee Member
2021 - Present
2021 - PresentFRONTIERS IN IMMUNOLOGY
Committee Member
2015 - Present
2015 - PresentNöropsikiyatri Arşivi
Editor
2011 - 2020
2011 - 2020EXPERIMED
First Editor
Memberships and Roles in Scientific Organizations
2021 - Present
2021 - PresentEuropean Academy of Neurology (EAN)
Member
2020 - Present
2020 - PresentNew York Academy of Sciences
Member
2001 - Present
2001 - PresentNöroimmünoloji Derneği
Board Member
2001 - Present
2001 - PresentNöropsikiyatri Derneği
Member
2000 - Present
2000 - PresentUlusal Nöroloji Derneği
Member
Peer Reviews in Scientific Publications
March 2016
March 2016Journal of Neurology Neurosurgery Psychiatry
SCI Journal
January 2016
January 2016Journal of Neurology
SCI Journal
January 2015
January 2015Plos One
SCI Journal
January 2015
January 2015Nöropsikiyatri Arşivi
National Scientific Refreed Journal
January 2012
January 2012European Journal of Immunology
SCI Journal
January 2012
January 2012Journal of Diabetes and its Complications
SCI Journal
January 2012
January 2012Journal of Neuroimmunology
SCI Journal
January 2011
January 2011Journal of the Neurological Sciences
SCI Journal
January 2011
January 2011Vaccine
SCI Journal
January 2010
January 2010Neuromuscular Disorders
SCI Journal
January 2010
January 2010Epilepsia
SCI Journal
January 2009
January 2009Acta Neuropathologica
SCI Journal
January 2008
January 2008Headache
SCI Journal
January 2006
January 2006European Journal of Neurology
SCI Journal
Mobility Activity
2021 - 2022
2021 - 2022Sabbatical Leave
Guest Researcher
University of Oxford, England
Awards
October 2024
October 2024Academic Performans Category, Over 40-Year-Old Award, Health Sciences Field
İstanbul Üniversitesi
December 2023
December 2023Otoimmün Demiyelizan Hastalıkların Ayırıcı Tanısında CCL4L2’nin B Hücre Temelli Biyobelirteç Olarak Değeri
59. Ulusal Nöroloji Kongresi
November 2017
November 201730th ECNP Congress of Applied and Translational Neuroscience CDE Grant
Ecnp Congress
September 2015
September 2015İstanbul Üniversitesi Başarılı Araştırmacı Ödülü
İstanbul Üniversitesi
September 2010
September 2010Türk Nöropsikiyatri Derneği Bilimsel Araştırma Ödülü
Türk Nöropsikiyatri Derneği
June 2004
June 2004James W. McLaughlin Postdoctoral Award for Excellence in Research on Infection and Immunity
Utmb Galveston
April 1999
April 1999Beyin Araştırmaları Derneği Proje Birincilik Ödülü
Beyin Araştırmaları Derneği
Invited Talks
February 2025
February 20251st IgG4-TREAT Winter School
Seminar
IgG4-TREAT Consortium-Austria
October 2024
October 20249th International Symposium on Neurodegeneration with Brain Iron Accumulation (NBIA)
Conference
NBIA-Turkey
September 2022
September 202232nd International Congress of Clinical Neurophysiology
Conference
Congress of Clinical Neurophysiology-Switzerland
June 2019
June 2019FENS Meeting
Conference
FENS-Serbia
May 2015
May 201531st International Epilepsy Congress
Conference
International Epilepsy Congress-Turkey
March 2009
March 2009International Conference on Myasthenia Gravis
Conference
International Conference on Myasthenia Gravis-France
May 2006
May 2006MDA Myasthenia Gravis Research Update
Seminar
Muscle Dystrophy Association-United States Of America
March 2006
March 2006GTCbio’s Modern Drug Discovery & Development Summit
Conference
GTCbio-United States Of America
June 2005
June 2005Annual ANA meeting
Conference
American Neurology Association (ANA)-Turkey
June 2005
June 2005MDA meeting
Conference
Muscular Dystrophy Association (MDA)-United States Of America
April 2003
April 2003Myasthenia Gravis Foundation of America Scientific Session
Conference
Myasthenia Gravis Foundation of America-United States Of America
Citations
Total Citations (WOS): 2931
h-index (WOS): 28
Scientific Research / Working Group Memberships
2021 - Present
2021 - PresentEan Task Force On Consensus Guidelines For The Management Of Autoimmune Encephalitis
https://www.ean.org/research/ean-guidelines/about-ean-guidelines-for-neurologists/ongoing-guidelines
EAN (European Academy of Neurology), Switzerland
2021 - Present
2021 - PresentNöroonkoloji Çalışma Grubu - Neuro-Oncology Board
https://www.ean.org/home/organisation/scientific-panels/neuro-oncology
EAN (European Academy of Neurology), Austria
2019 - Present
2019 - PresentTranslasyonel Nörobilim - Translational Neuroscience
https://www.noroloji.org.tr/altbirim/34/translasyonel-norobilim/kosullar/
Istanbul University, Turkey
2019 - 2022
2019 - 2022